Psyllid ID: psy620
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1290 | 2.2.26 [Sep-21-2011] | |||||||
| P49744 | 980 | Thrombospondin-4 OS=Rattu | yes | N/A | 0.407 | 0.536 | 0.486 | 1e-119 | |
| P35443 | 961 | Thrombospondin-4 OS=Homo | yes | N/A | 0.401 | 0.539 | 0.487 | 1e-118 | |
| P49746 | 956 | Thrombospondin-3 OS=Homo | no | N/A | 0.417 | 0.563 | 0.472 | 1e-118 | |
| Q05895 | 956 | Thrombospondin-3 OS=Mus m | yes | N/A | 0.417 | 0.563 | 0.474 | 1e-117 | |
| Q9Z1T2 | 963 | Thrombospondin-4 OS=Mus m | no | N/A | 0.410 | 0.550 | 0.485 | 1e-115 | |
| Q3SWW8 | 961 | Thrombospondin-4 OS=Bos t | no | N/A | 0.416 | 0.558 | 0.479 | 1e-115 | |
| Q8JHW2 | 962 | Thrombospondin-3a OS=Dani | yes | N/A | 0.297 | 0.399 | 0.553 | 1e-112 | |
| Q06441 | 955 | Thrombospondin-4 OS=Xenop | N/A | N/A | 0.416 | 0.562 | 0.463 | 1e-112 | |
| Q9R0G6 | 755 | Cartilage oligomeric matr | no | N/A | 0.426 | 0.728 | 0.463 | 1e-111 | |
| P35448 | 1173 | Thrombospondin-1 OS=Xenop | N/A | N/A | 0.441 | 0.485 | 0.429 | 1e-111 |
| >sp|P49744|TSP4_RAT Thrombospondin-4 OS=Rattus norvegicus GN=Thbs4 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 429 bits (1104), Expect = e-119, Method: Compositional matrix adjust.
Identities = 287/590 (48%), Positives = 345/590 (58%), Gaps = 64/590 (10%)
Query: 594 NPCFPGVECRDTREGPRCMRCPDGYVGDGIHCKPGVTCNMRPCFQGVQCFDTVFNASIRL 653
+PCF GV C DTR+G +C CPDGY G+GI C C PC+ GV+C T R
Sbjct: 311 SPCFRGVRCTDTRDGFQCGPCPDGYTGNGITCSDVDECKYHPCYPGVRC--TNLAPGFRC 368
Query: 654 KVTHVVLVRLDTQEMVRDV---------NALVDVRATRALKASVRCDDIPEHPYYRCGSC 704
V T MV+ V DV R + I YRCG C
Sbjct: 369 DACPVGF----TGPMVQGVGINFAKTNKQVCTDVDECRNGACVLNSICINTLGSYRCGPC 424
Query: 705 PEGTTGNGTR-------CHDIDEDNC-VHIPNSGQEDAD---------EDNIGDICDDDA 747
G TG+ TR C + +++ C VH + D G +C D
Sbjct: 425 KPGYTGDQTRGCRTERSCRNPEQNPCSVHAQCIEERQGDVTCVCGVGWAGRAGYVCGKDV 484
Query: 748 DNDGILN----------PSDNCPYVHNPDQLDSDQDGMRDRRLGDACDN--------CPT 789
D D + DNC YV N Q D+D+DG +GDACD
Sbjct: 485 DIDSYPDEELPCSARNCKKDNCKYVPNSGQEDADRDG-----IGDACDEDADGDGILNEQ 539
Query: 790 DNCPYVHNPDQLDSDQDGMRDRRLGDACDNCPTVPNVDQTDTDNDGTGDACDNDMDNDGI 849
DNC HN DQ ++D+D GDACDNC V N DQ DTD DG GDACD+DMD DGI
Sbjct: 540 DNCVLTHNVDQRNTDKD-----IFGDACDNCRGVLNNDQKDTDGDGKGDACDDDMDGDGI 594
Query: 850 NNHADNCPRNANPDQRDSDHDGIGDACDNCPRVSNPEQTDSNSNHIGDVCDSGVDTDHDG 909
N DNCPR N DQ+D D DG+GDACD+CP VSNP Q+D +++ +GD CD+ D+D DG
Sbjct: 595 KNILDNCPRVPNRDQQDRDGDGVGDACDSCPDVSNPNQSDVDNDLVGDSCDTNQDSDGDG 654
Query: 910 VPDPMDNCPKVANPNQLDNDRDGKGDECDPDLDGDGISN----DEDNCRLIYNPNQDDSD 965
D DNCP V N QLD D+DG GDECD D D DG+ + DNCRL+ NP Q+DS+
Sbjct: 655 HQDSTDNCPTVINSAQLDTDKDGIGDECDDDDDNDGMPDLFPPGPDNCRLVPNPAQEDSN 714
Query: 966 GDGVGNVCDKDFDKDGTPDVSDVCPNNSLVYRTDFRRYTTVILDPQGTSQIDPHWVIYNH 1025
DGVG++C+ DFD+D D DVCP N+ + TDFR Y TV+LDP+G +QIDP+WV+ N
Sbjct: 715 NDGVGDICEADFDQDKVIDRIDVCPENAEITLTDFRAYQTVVLDPEGDAQIDPNWVVLNQ 774
Query: 1026 GAEILQTMNSDPGLAIGQDKFSGVDFEGTFFVDTDIDDDYAGFVFSYQSSQKFYVMMWKK 1085
G EI+QTMNSDPGLA+G F+GVDFEGTF V+T DDDYAGF+F YQ S FYV+MWK+
Sbjct: 775 GMEIVQTMNSDPGLAVGYTAFNGVDFEGTFHVNTQTDDDYAGFIFGYQDSSSFYVVMWKQ 834
Query: 1086 NSQVYWQTTPFRAVAEPGIQLKVVDSATGPGTMLRNSLWHTGDTENQCDL 1135
Q YWQ TPFRAVAEPGIQLK V S TGPG LRNSLWHTGDT +Q L
Sbjct: 835 TEQTYWQATPFRAVAEPGIQLKAVKSKTGPGEHLRNSLWHTGDTSDQVRL 884
|
Acts as an extracellular mitogen and stimulates early erythroid progenitors proliferation in presence of EPO. Adhesive glycoprotein that mediates cell-to-cell and cell-to-matrix interactions. Can bind to fibrinogen, fibronectin, laminin and type V collagen. Rattus norvegicus (taxid: 10116) |
| >sp|P35443|TSP4_HUMAN Thrombospondin-4 OS=Homo sapiens GN=THBS4 PE=1 SV=2 | Back alignment and function description |
|---|
| >sp|P49746|TSP3_HUMAN Thrombospondin-3 OS=Homo sapiens GN=THBS3 PE=2 SV=1 | Back alignment and function description |
|---|
| >sp|Q05895|TSP3_MOUSE Thrombospondin-3 OS=Mus musculus GN=Thbs3 PE=1 SV=2 | Back alignment and function description |
|---|
| >sp|Q9Z1T2|TSP4_MOUSE Thrombospondin-4 OS=Mus musculus GN=Thbs4 PE=1 SV=1 | Back alignment and function description |
|---|
| >sp|Q3SWW8|TSP4_BOVIN Thrombospondin-4 OS=Bos taurus GN=THBS4 PE=2 SV=1 | Back alignment and function description |
|---|
| >sp|Q8JHW2|TSP3A_DANRE Thrombospondin-3a OS=Danio rerio GN=thbs3a PE=2 SV=2 | Back alignment and function description |
|---|
| >sp|Q06441|TSP4_XENLA Thrombospondin-4 OS=Xenopus laevis GN=thbs4 PE=2 SV=1 | Back alignment and function description |
|---|
| >sp|Q9R0G6|COMP_MOUSE Cartilage oligomeric matrix protein OS=Mus musculus GN=Comp PE=1 SV=2 | Back alignment and function description |
|---|
| >sp|P35448|TSP1_XENLA Thrombospondin-1 OS=Xenopus laevis GN=thbs1 PE=2 SV=1 | Back alignment and function description |
|---|
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1290 | ||||||
| 328706983 | 1061 | PREDICTED: thrombospondin-3-like [Acyrth | 0.304 | 0.370 | 0.629 | 1e-141 | |
| 157117627 | 1064 | thrombospondin [Aedes aegypti] gi|108875 | 0.397 | 0.482 | 0.506 | 1e-138 | |
| 242015135 | 1018 | Thrombospondin-3 precursor, putative [Pe | 0.418 | 0.530 | 0.498 | 1e-138 | |
| 347967276 | 1066 | AGAP002157-PA [Anopheles gambiae str. PE | 0.397 | 0.481 | 0.506 | 1e-136 | |
| 170050552 | 817 | thrombospondin [Culex quinquefasciatus] | 0.397 | 0.627 | 0.498 | 1e-135 | |
| 357616511 | 1129 | hypothetical protein KGM_00807 [Danaus p | 0.410 | 0.468 | 0.467 | 1e-130 | |
| 312373493 | 466 | hypothetical protein AND_17370 [Anophele | 0.296 | 0.819 | 0.592 | 1e-129 | |
| 345492742 | 1044 | PREDICTED: thrombospondin-3-like [Nasoni | 0.424 | 0.524 | 0.468 | 1e-129 | |
| 241999578 | 789 | thrombospondin, putative [Ixodes scapula | 0.415 | 0.679 | 0.495 | 1e-128 | |
| 2384644 | 851 | thrombospondin-3 [Xenopus laevis] | 0.446 | 0.676 | 0.458 | 1e-122 |
| >gi|328706983|ref|XP_001948462.2| PREDICTED: thrombospondin-3-like [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 510 bits (1313), Expect = e-141, Method: Compositional matrix adjust.
Identities = 272/432 (62%), Positives = 315/432 (72%), Gaps = 39/432 (9%)
Query: 711 NGTRCHDIDEDNCVHIPNSGQEDADEDNIGDICDDDADNDGILNPSDNCPYVHNPDQLDS 770
N TRC +DNCV +PNSGQEDAD D IGD+CDDDADNDG+ N DNC
Sbjct: 571 NDTRCK---KDNCVRVPNSGQEDADHDGIGDVCDDDADNDGVPNTPDNC----------- 616
Query: 771 DQDGMRDRRLGDACDNCPTDNCPYVHNPDQLDSDQDGMRDRRLGDACDNCPTVPNVDQTD 830
P V NPDQ+DSDQDG + GDACDNCPT+PN+DQ D
Sbjct: 617 ----------------------PLVSNPDQMDSDQDGADKK--GDACDNCPTIPNLDQHD 652
Query: 831 TDNDGTGDACDNDMDNDGINNHADNCPRNANPDQRDSDHDGIGDACDNCPRVSNPEQTDS 890
TDNDG GDACD D+DNDG+ NH DNCP+ ANPDQRD+D DG+GD CDNCP + NP QTDS
Sbjct: 653 TDNDGIGDACDADIDNDGVLNHEDNCPKKANPDQRDTDGDGLGDVCDNCPSMHNPTQTDS 712
Query: 891 NSNHIGDVCDSGVDTDHDGVPDPMDNCPKVANPNQLDNDRDGKGDECDPDLDGDGISNDE 950
+ + IGD CDS +D D DG+ D +DNCPKVAN NQLD D DGKGDECDPD+DGDGI N +
Sbjct: 713 DKDLIGDACDSDIDRDRDGIQDSVDNCPKVANSNQLDTDGDGKGDECDPDIDGDGIGNTQ 772
Query: 951 DNCRLIYNPNQDDSDGDGVGNVCDKDFDKDGTPDVSDVCPNNSLVYRTDFRRYTTVILDP 1010
DNC L+YNP+Q D DG+G+G++C D D D P+ D CPNNS ++ TDFR Y TV+LDP
Sbjct: 773 DNCMLVYNPDQADFDGNGIGDICQDDNDYDKVPNHLDNCPNNSKIFTTDFRTYQTVVLDP 832
Query: 1011 QGTSQIDPHWVIYNHGAEILQTMNSDPGLAIGQDKFSGVDFEGTFFVDTDIDDDYAGFVF 1070
+G SQIDP+WV+YN GAE +QTMNSDPGLA+G D F GVDFEGTFFVDTDIDDDY GFVF
Sbjct: 833 EGDSQIDPNWVVYNKGAEFVQTMNSDPGLAVGYDSFGGVDFEGTFFVDTDIDDDYVGFVF 892
Query: 1071 SYQSSQKFYVMMWKKNSQVYWQTTPFRAVAEPGIQLKVVDSATGPGTMLRNSLWHTGDTE 1130
SYQ + KFY +MWKK +Q YWQ TPFRAVAEPGIQ+K V S TGPG MLRN+LW+T T+
Sbjct: 893 SYQDNHKFYTVMWKKGTQTYWQATPFRAVAEPGIQIKAVHSETGPGQMLRNALWNTESTD 952
Query: 1131 NQCDLAEPCDPR 1142
Q L DPR
Sbjct: 953 KQVKLLWK-DPR 963
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|157117627|ref|XP_001658858.1| thrombospondin [Aedes aegypti] gi|108875947|gb|EAT40172.1| AAEL008062-PA, partial [Aedes aegypti] | Back alignment and taxonomy information |
|---|
| >gi|242015135|ref|XP_002428229.1| Thrombospondin-3 precursor, putative [Pediculus humanus corporis] gi|212512790|gb|EEB15491.1| Thrombospondin-3 precursor, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
| >gi|347967276|ref|XP_308033.5| AGAP002157-PA [Anopheles gambiae str. PEST] gi|333466370|gb|EAA03707.5| AGAP002157-PA [Anopheles gambiae str. PEST] | Back alignment and taxonomy information |
|---|
| >gi|170050552|ref|XP_001861362.1| thrombospondin [Culex quinquefasciatus] gi|167872159|gb|EDS35542.1| thrombospondin [Culex quinquefasciatus] | Back alignment and taxonomy information |
|---|
| >gi|357616511|gb|EHJ70238.1| hypothetical protein KGM_00807 [Danaus plexippus] | Back alignment and taxonomy information |
|---|
| >gi|312373493|gb|EFR21222.1| hypothetical protein AND_17370 [Anopheles darlingi] | Back alignment and taxonomy information |
|---|
| >gi|345492742|ref|XP_001599611.2| PREDICTED: thrombospondin-3-like [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
| >gi|241999578|ref|XP_002434432.1| thrombospondin, putative [Ixodes scapularis] gi|215497762|gb|EEC07256.1| thrombospondin, putative [Ixodes scapularis] | Back alignment and taxonomy information |
|---|
| >gi|2384644|gb|AAB69765.1| thrombospondin-3 [Xenopus laevis] | Back alignment and taxonomy information |
|---|
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1290 | ||||||
| FB|FBgn0031850 | 1060 | Tsp "Thrombospondin" [Drosophi | 0.294 | 0.358 | 0.519 | 3.5e-139 | |
| UNIPROTKB|F1NBP0 | 953 | THBS4 "Uncharacterized protein | 0.294 | 0.398 | 0.552 | 5.7e-135 | |
| UNIPROTKB|G3XAP6 | 724 | COMP "Cartilage oligomeric mat | 0.405 | 0.722 | 0.460 | 2.9e-133 | |
| UNIPROTKB|P49747 | 757 | COMP "Cartilage oligomeric mat | 0.405 | 0.690 | 0.460 | 2.9e-133 | |
| RGD|2378 | 755 | Comp "cartilage oligomeric mat | 0.290 | 0.496 | 0.553 | 1.5e-132 | |
| UNIPROTKB|F1S902 | 756 | COMP "Uncharacterized protein" | 0.293 | 0.501 | 0.548 | 7.3e-131 | |
| UNIPROTKB|P35445 | 756 | COMP "Cartilage oligomeric mat | 0.293 | 0.501 | 0.543 | 3.1e-130 | |
| RGD|1310979 | 1172 | Thbs2 "thrombospondin 2" [Ratt | 0.283 | 0.312 | 0.520 | 4.8e-130 | |
| ZFIN|ZDB-GENE-080917-12 | 749 | im:7154332 "im:7154332" [Danio | 0.286 | 0.492 | 0.544 | 1.5e-128 | |
| ZFIN|ZDB-GENE-020708-3 | 962 | thbs3a "thrombospondin 3a" [Da | 0.293 | 0.393 | 0.544 | 5.5e-128 |
| FB|FBgn0031850 Tsp "Thrombospondin" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 1092 (389.5 bits), Expect = 3.5e-139, Sum P(3) = 3.5e-139
Identities = 202/389 (51%), Positives = 257/389 (66%)
Query: 757 DNCPYVHNPDQLDSDQDGMRDRRLGDAC-DNCPT--DNCPYVHNPDQLDSDQDGMRDRRL 813
DNCP + N Q D+D DG D DA DN DNC +N +QLDSD D ++
Sbjct: 585 DNCPKLPNSGQEDADLDGHGDGCDDDADGDNVQNSQDNCWLAYNTEQLDSDGD-----KV 639
Query: 814 GDACDNCPTVPXXXXXXXXXXXXXXXXXXXMDNDGINNHADNCPRNANPDQRDSDHDGIG 873
GD CDNC +DND I N DNCP NP Q D D+DG+G
Sbjct: 640 GDVCDNCVLKYNPRQLDTDEDGLGDECDGDIDNDSIPNALDNCPLLPNPSQSDVDNDGVG 699
Query: 874 DACDNCPRVSNPEQTDSNSNHIGDVCDSGVDTDHDGVPDPMDNCPKVANPNQLDNDRDGK 933
DACDNCP + NP+Q D + + +GD C +D D DGVP+ +DNCP V+N +QLD D DG
Sbjct: 700 DACDNCPNLPNPDQKDRDMDFVGDACHRDIDGDDDGVPNSLDNCPMVSNSDQLDTDGDGT 759
Query: 934 GDECDPDLDGDGISNDEDNCRLIYNPNQDDSDGDGVGNVCDKDFDKDGTPDVSDVCPNNS 993
GDECD D+DGDGI N +DNC L NP QDD + +G G+ C+ D D DG P+ D CPNNS
Sbjct: 760 GDECDDDMDGDGIPNYKDNCPLAKNPKQDDFNRNGKGDSCEDDEDVDGVPNGMDNCPNNS 819
Query: 994 LVYRTDFRRYTTVILDPQGTSQIDPHWVIYNHGAEILQTMNSDPGLAIGQDKFSGVDFEG 1053
+++ TDFR T+ LDP+G SQ DP+WV++ +G EI+QT+NSDPGLA+G+D F GVDF+G
Sbjct: 820 MIHHTDFRTLQTIPLDPKGLSQADPNWVVHANGTEIVQTLNSDPGLAVGKDAFGGVDFDG 879
Query: 1054 TFFVDTDIDDDYAGFVFSYQSSQKFYVMMWKKNSQVYWQTTPFRAVAEPGIQLKVVDSAT 1113
TF+++ D DDDYAGFVFSYQSS K+YV+ WKK +Q YW+ PF A A PGIQ+K+V+S
Sbjct: 880 TFYINDDTDDDYAGFVFSYQSSYKYYVVQWKKGTQTYWEPRPFTASAAPGIQIKLVNSTE 939
Query: 1114 GPGTMLRNSLWHTGDTENQCDLAEPCDPR 1142
GPG M+RNSLWH G+T+ + L DP+
Sbjct: 940 GPGPMMRNSLWHEGNTDGEARLLWK-DPK 967
|
|
| UNIPROTKB|F1NBP0 THBS4 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|G3XAP6 COMP "Cartilage oligomeric matrix protein, isoform CRA_b" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|P49747 COMP "Cartilage oligomeric matrix protein" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
| RGD|2378 Comp "cartilage oligomeric matrix protein" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F1S902 COMP "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|P35445 COMP "Cartilage oligomeric matrix protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
| RGD|1310979 Thbs2 "thrombospondin 2" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
| ZFIN|ZDB-GENE-080917-12 im:7154332 "im:7154332" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
| ZFIN|ZDB-GENE-020708-3 thbs3a "thrombospondin 3a" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1290 | |||
| pfam05735 | 201 | pfam05735, TSP_C, Thrombospondin C-terminal region | 2e-71 | |
| pfam05735 | 201 | pfam05735, TSP_C, Thrombospondin C-terminal region | 2e-29 | |
| pfam02412 | 35 | pfam02412, TSP_3, Thrombospondin type 3 repeat | 2e-08 | |
| pfam02412 | 35 | pfam02412, TSP_3, Thrombospondin type 3 repeat | 1e-06 | |
| pfam02412 | 35 | pfam02412, TSP_3, Thrombospondin type 3 repeat | 4e-06 | |
| pfam02412 | 35 | pfam02412, TSP_3, Thrombospondin type 3 repeat | 2e-05 | |
| pfam02412 | 35 | pfam02412, TSP_3, Thrombospondin type 3 repeat | 2e-05 | |
| cd00054 | 38 | cd00054, EGF_CA, Calcium-binding EGF-like domain, | 2e-05 | |
| smart00179 | 39 | smart00179, EGF_CA, Calcium-binding EGF-like domai | 7e-05 | |
| pfam02412 | 35 | pfam02412, TSP_3, Thrombospondin type 3 repeat | 1e-04 | |
| pfam07645 | 42 | pfam07645, EGF_CA, Calcium-binding EGF domain | 0.002 | |
| smart00179 | 39 | smart00179, EGF_CA, Calcium-binding EGF-like domai | 0.003 | |
| pfam12947 | 36 | pfam12947, EGF_3, EGF domain | 0.004 |
| >gnl|CDD|147730 pfam05735, TSP_C, Thrombospondin C-terminal region | Back alignment and domain information |
|---|
Score = 236 bits (605), Expect = 2e-71
Identities = 88/121 (72%), Positives = 100/121 (82%)
Query: 1015 QIDPHWVIYNHGAEILQTMNSDPGLAIGQDKFSGVDFEGTFFVDTDIDDDYAGFVFSYQS 1074
QIDP+WV+YN GAEI+QT+NSDPGLA+G D F GVDFEGTFF++T DDDY GFVF YQS
Sbjct: 1 QIDPNWVVYNQGAEIVQTLNSDPGLAVGYDAFEGVDFEGTFFINTTTDDDYVGFVFGYQS 60
Query: 1075 SQKFYVMMWKKNSQVYWQTTPFRAVAEPGIQLKVVDSATGPGTMLRNSLWHTGDTENQCD 1134
+ KFYV+MWKK Q YWQ PFRA AEPGIQLK+V+S TGPG LRN+LWHTGDT NQ
Sbjct: 61 NSKFYVVMWKKAEQTYWQANPFRASAEPGIQLKLVNSTTGPGEALRNALWHTGDTTNQVR 120
Query: 1135 L 1135
L
Sbjct: 121 L 121
|
This region is found at the C-terminus of thrombospondin and related proteins. Length = 201 |
| >gnl|CDD|147730 pfam05735, TSP_C, Thrombospondin C-terminal region | Back alignment and domain information |
|---|
| >gnl|CDD|202235 pfam02412, TSP_3, Thrombospondin type 3 repeat | Back alignment and domain information |
|---|
| >gnl|CDD|202235 pfam02412, TSP_3, Thrombospondin type 3 repeat | Back alignment and domain information |
|---|
| >gnl|CDD|202235 pfam02412, TSP_3, Thrombospondin type 3 repeat | Back alignment and domain information |
|---|
| >gnl|CDD|202235 pfam02412, TSP_3, Thrombospondin type 3 repeat | Back alignment and domain information |
|---|
| >gnl|CDD|202235 pfam02412, TSP_3, Thrombospondin type 3 repeat | Back alignment and domain information |
|---|
| >gnl|CDD|238011 cd00054, EGF_CA, Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins | Back alignment and domain information |
|---|
| >gnl|CDD|214542 smart00179, EGF_CA, Calcium-binding EGF-like domain | Back alignment and domain information |
|---|
| >gnl|CDD|202235 pfam02412, TSP_3, Thrombospondin type 3 repeat | Back alignment and domain information |
|---|
| >gnl|CDD|219496 pfam07645, EGF_CA, Calcium-binding EGF domain | Back alignment and domain information |
|---|
| >gnl|CDD|214542 smart00179, EGF_CA, Calcium-binding EGF-like domain | Back alignment and domain information |
|---|
| >gnl|CDD|205157 pfam12947, EGF_3, EGF domain | Back alignment and domain information |
|---|
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1290 | |||
| PF05735 | 201 | TSP_C: Thrombospondin C-terminal region; InterPro: | 100.0 | |
| PF05735 | 201 | TSP_C: Thrombospondin C-terminal region; InterPro: | 100.0 | |
| KOG1214|consensus | 1289 | 99.85 | ||
| KOG1214|consensus | 1289 | 99.73 | ||
| KOG4289|consensus | 2531 | 99.72 | ||
| KOG4289|consensus | 2531 | 99.64 | ||
| KOG0994|consensus | 1758 | 99.63 | ||
| KOG1219|consensus | 4289 | 99.61 | ||
| KOG1217|consensus | 487 | 99.57 | ||
| KOG1219|consensus | 4289 | 99.48 | ||
| KOG1217|consensus | 487 | 99.44 | ||
| KOG0994|consensus | 1758 | 99.11 | ||
| KOG4260|consensus | 350 | 98.72 | ||
| PF02412 | 36 | TSP_3: Thrombospondin type 3 repeat; InterPro: IPR | 98.58 | |
| KOG1836|consensus | 1705 | 98.58 | ||
| KOG4260|consensus | 350 | 98.56 | ||
| PF02412 | 36 | TSP_3: Thrombospondin type 3 repeat; InterPro: IPR | 98.55 | |
| KOG1225|consensus | 525 | 98.45 | ||
| KOG1225|consensus | 525 | 98.38 | ||
| KOG1836|consensus | 1705 | 97.75 | ||
| PF07645 | 42 | EGF_CA: Calcium-binding EGF domain; InterPro: IPR0 | 97.6 | |
| PF12947 | 36 | EGF_3: EGF domain; InterPro: IPR024731 This entry | 97.45 | |
| KOG1226|consensus | 783 | 97.36 | ||
| KOG1226|consensus | 783 | 97.07 | ||
| PF00008 | 32 | EGF: EGF-like domain This is a sub-family of the P | 97.0 | |
| PF07645 | 42 | EGF_CA: Calcium-binding EGF domain; InterPro: IPR0 | 96.97 | |
| smart00179 | 39 | EGF_CA Calcium-binding EGF-like domain. | 96.73 | |
| PF00008 | 32 | EGF: EGF-like domain This is a sub-family of the P | 96.6 | |
| smart00179 | 39 | EGF_CA Calcium-binding EGF-like domain. | 96.58 | |
| PF12947 | 36 | EGF_3: EGF domain; InterPro: IPR024731 This entry | 96.53 | |
| PF06247 | 197 | Plasmod_Pvs28: Plasmodium ookinete surface protein | 96.47 | |
| PF12662 | 24 | cEGF: Complement Clr-like EGF-like | 96.19 | |
| PF06247 | 197 | Plasmod_Pvs28: Plasmodium ookinete surface protein | 96.15 | |
| cd00054 | 38 | EGF_CA Calcium-binding EGF-like domain, present in | 95.96 | |
| cd00054 | 38 | EGF_CA Calcium-binding EGF-like domain, present in | 95.93 | |
| PF12662 | 24 | cEGF: Complement Clr-like EGF-like | 95.92 | |
| PF14670 | 36 | FXa_inhibition: Coagulation Factor Xa inhibitory s | 95.77 | |
| cd00053 | 36 | EGF Epidermal growth factor domain, found in epide | 94.89 | |
| cd00053 | 36 | EGF Epidermal growth factor domain, found in epide | 94.61 | |
| smart00181 | 35 | EGF Epidermal growth factor-like domain. | 94.38 | |
| smart00181 | 35 | EGF Epidermal growth factor-like domain. | 94.28 | |
| KOG1218|consensus | 316 | 91.54 | ||
| PF14670 | 36 | FXa_inhibition: Coagulation Factor Xa inhibitory s | 88.43 | |
| KOG1218|consensus | 316 | 87.97 | ||
| PF12661 | 13 | hEGF: Human growth factor-like EGF; PDB: 2YGQ_A 2E | 87.3 | |
| PF07974 | 32 | EGF_2: EGF-like domain; InterPro: IPR013111 A sequ | 85.44 | |
| cd01475 | 224 | vWA_Matrilin VWA_Matrilin: In cartilaginous plate, | 85.37 | |
| KOG3514|consensus | 1591 | 83.22 | ||
| KOG3512|consensus | 592 | 82.69 | ||
| PF00683 | 42 | TB: TB domain; InterPro: IPR002212 Transforming gr | 82.61 | |
| PF07974 | 32 | EGF_2: EGF-like domain; InterPro: IPR013111 A sequ | 82.59 | |
| KOG3516|consensus | 1306 | 81.55 | ||
| PF12946 | 37 | EGF_MSP1_1: MSP1 EGF domain 1; InterPro: IPR024730 | 81.4 |
| >PF05735 TSP_C: Thrombospondin C-terminal region; InterPro: IPR008859 Thrombospondins are multimeric multidomain glycoproteins that function at cell surfaces and in the extracellular matrix milieu | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=365.48 Aligned_cols=138 Identities=64% Similarity=1.137 Sum_probs=106.7
Q ss_pred CCCCceeeccCCceEEEeecCCCCcccccccccceeeecceeecccCCCCccceEeeeccCCcEEEEeccccceeeeecc
Q psy620 1015 QIDPHWVIYNHGAEILQTMNSDPGLAIGQDKFSGVDFEGTFFVDTDIDDDYAGFVFSYQSSQKFYVMMWKKNSQVYWQTT 1094 (1290)
Q Consensus 1015 ~~d~~~~v~~~g~~~~q~~~~dp~~~~g~~~~~~~d~~g~~~~~~~~d~~~~gfvf~yq~~~~f~~~~~~~~~~~~w~~~ 1094 (1290)
|.||+|+|.++|+||+|++||||+++||.++|.+|||+|||+|++..|||||||||+||+|+||||||||+..|+||+.+
T Consensus 1 q~dP~W~v~~~G~ev~Qt~NsdP~l~ig~~~~~~vdf~GT~~Vnt~~DDDyiGFVFGYQsn~~FYvv~WKq~~Q~y~~~~ 80 (201)
T PF05735_consen 1 QIDPNWVVSNQGAEVVQTLNSDPGLAIGPDNFGGVDFSGTFFVNTTSDDDYIGFVFGYQSNRKFYVVMWKQGNQNYWESS 80 (201)
T ss_dssp S----EEEECCCTEEEE-SS-SSEEEEEEEEESSEEEEEEEEE--SS---EEEEEEEEEETTEEEEEEEESS-EE-S--S
T ss_pred CCCCceEEecCCeEEEEeccCCCeEEEccceecceEEEEEEEEecCCCCCEEEEEEEecCCCeEEEEEeeccccccccCC
Confidence 67999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCccEEEEecCCCCCCcccccccccCCCcccccccCCCcCCCcccccCCCCcc
Q psy620 1095 PFRAVAEPGIQLKVVDSATGPGTMLRNSLWHTGDTENQCDLAEPCDPRVQCTNLFPGYR 1153 (1290)
Q Consensus 1095 ~f~~~~~~g~~~~~~~~~~~~~~~~~~~~w~~~~~~~q~~~~w~~~~~~~~~~~~~~~~ 1153 (1290)
||||.|++|||+|+|+|+||||++|||+|||+++|.+||++||+ +|...+|+....|+
T Consensus 81 p~~~~a~~Gl~iK~V~s~tGpg~~l~nalWh~~~t~~qv~llw~-dp~~~GW~~~t~Y~ 138 (201)
T PF05735_consen 81 PFRATAEPGLQIKLVDSTTGPGEMLRNALWHTGDTTNQVKLLWH-DPGNIGWKDNTAYR 138 (201)
T ss_dssp SS--EE-SEEEEEEEE-SS-TTHHHHHHHHSSS-BTTTEEEEEE--TT-----TT-EEE
T ss_pred CccccccceEEEEEEecCcCCchhhhhhhccCCCccceeEEEEe-CCCcCCCcCCccEE
Confidence 99999999999999999999999999999999999999999999 88777776655554
|
They act as regulators of cell interactions in vertebrates. They are divided into two subfamilies, A and B, according to their overall molecular organisation. The subgroup A proteins TSP-1 and -2 contain an N-terminal domain, a VWFC domain, three TSP1 repeats, three EGF-like domains, TSP3 repeats and a C-terminal domain. They are assembled as trimer. The subgroup B thrombospondins, designated TSP-3, -4, and COMP (cartilage oligomeric matrix protein, also designated TSP-5) are distinct in that they contain unique N-terminal regions, lack the VWFC domain and TSP1 repeats, contain four copies of EGF-like domains, and are assembled as pentamers []. EGF, TSP3 repeats and the C-terminal domain are thus the hallmark of a thrombospondin. The globular C-terminal domain is a beta sandwich of two curved antiparallel beta-sheets []. The fold is an elaboration of the jelly role topology, with strand B3-B7, B11 and B14-B15 forming the eight-stranded jelly roll motif. The function of the C-terminal domain is not yet known.; GO: 0005509 calcium ion binding, 0007155 cell adhesion, 0005576 extracellular region; PDB: 1UX6_A 1YO8_A 2RHP_A 3FBY_C. |
| >PF05735 TSP_C: Thrombospondin C-terminal region; InterPro: IPR008859 Thrombospondins are multimeric multidomain glycoproteins that function at cell surfaces and in the extracellular matrix milieu | Back alignment and domain information |
|---|
| >KOG1214|consensus | Back alignment and domain information |
|---|
| >KOG1214|consensus | Back alignment and domain information |
|---|
| >KOG4289|consensus | Back alignment and domain information |
|---|
| >KOG4289|consensus | Back alignment and domain information |
|---|
| >KOG0994|consensus | Back alignment and domain information |
|---|
| >KOG1219|consensus | Back alignment and domain information |
|---|
| >KOG1217|consensus | Back alignment and domain information |
|---|
| >KOG1219|consensus | Back alignment and domain information |
|---|
| >KOG1217|consensus | Back alignment and domain information |
|---|
| >KOG0994|consensus | Back alignment and domain information |
|---|
| >KOG4260|consensus | Back alignment and domain information |
|---|
| >PF02412 TSP_3: Thrombospondin type 3 repeat; InterPro: IPR003367 Thrombospondins are multimeric multidomain glycoproteins that function at cell surfaces and in the extracellular matrix milieu | Back alignment and domain information |
|---|
| >KOG1836|consensus | Back alignment and domain information |
|---|
| >KOG4260|consensus | Back alignment and domain information |
|---|
| >PF02412 TSP_3: Thrombospondin type 3 repeat; InterPro: IPR003367 Thrombospondins are multimeric multidomain glycoproteins that function at cell surfaces and in the extracellular matrix milieu | Back alignment and domain information |
|---|
| >KOG1225|consensus | Back alignment and domain information |
|---|
| >KOG1225|consensus | Back alignment and domain information |
|---|
| >KOG1836|consensus | Back alignment and domain information |
|---|
| >PF07645 EGF_CA: Calcium-binding EGF domain; InterPro: IPR001881 A sequence of about forty amino-acid residues found in epidermal growth factor (EGF) has been shown [, , , , , ] to be present in a large number of membrane-bound and extracellular, mostly animal, proteins | Back alignment and domain information |
|---|
| >PF12947 EGF_3: EGF domain; InterPro: IPR024731 This entry represents an EGF domain found in the the C terminus of malarial parasite merozoite surface protein 1 [], as well as other proteins | Back alignment and domain information |
|---|
| >KOG1226|consensus | Back alignment and domain information |
|---|
| >KOG1226|consensus | Back alignment and domain information |
|---|
| >PF00008 EGF: EGF-like domain This is a sub-family of the Pfam entry This is a sub-family of the Pfam entry; InterPro: IPR006209 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins | Back alignment and domain information |
|---|
| >PF07645 EGF_CA: Calcium-binding EGF domain; InterPro: IPR001881 A sequence of about forty amino-acid residues found in epidermal growth factor (EGF) has been shown [, , , , , ] to be present in a large number of membrane-bound and extracellular, mostly animal, proteins | Back alignment and domain information |
|---|
| >smart00179 EGF_CA Calcium-binding EGF-like domain | Back alignment and domain information |
|---|
| >PF00008 EGF: EGF-like domain This is a sub-family of the Pfam entry This is a sub-family of the Pfam entry; InterPro: IPR006209 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins | Back alignment and domain information |
|---|
| >smart00179 EGF_CA Calcium-binding EGF-like domain | Back alignment and domain information |
|---|
| >PF12947 EGF_3: EGF domain; InterPro: IPR024731 This entry represents an EGF domain found in the the C terminus of malarial parasite merozoite surface protein 1 [], as well as other proteins | Back alignment and domain information |
|---|
| >PF06247 Plasmod_Pvs28: Plasmodium ookinete surface protein Pvs28; InterPro: IPR010423 This family consists of several ookinete surface protein (Pvs28) from several species of Plasmodium | Back alignment and domain information |
|---|
| >PF12662 cEGF: Complement Clr-like EGF-like | Back alignment and domain information |
|---|
| >PF06247 Plasmod_Pvs28: Plasmodium ookinete surface protein Pvs28; InterPro: IPR010423 This family consists of several ookinete surface protein (Pvs28) from several species of Plasmodium | Back alignment and domain information |
|---|
| >cd00054 EGF_CA Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins | Back alignment and domain information |
|---|
| >cd00054 EGF_CA Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins | Back alignment and domain information |
|---|
| >PF12662 cEGF: Complement Clr-like EGF-like | Back alignment and domain information |
|---|
| >PF14670 FXa_inhibition: Coagulation Factor Xa inhibitory site; PDB: 3Q3K_B 1NFY_B 1LQD_A 1G2L_B 1IQF_L 2UWP_B 2VH6_B 3KQC_L 2P93_L 2BQW_A | Back alignment and domain information |
|---|
| >cd00053 EGF Epidermal growth factor domain, found in epidermal growth factor (EGF) presents in a large number of proteins, mostly animal; the list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied; the functional significance of EGF-like domains in what appear to be unrelated proteins is not yet clear; a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase); the domain includes six cysteine residues which have been shown to be involved in disulfide bonds; the main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet; Subdomains between the conserved cysteines vary in length; the region between the 5th and 6th cysteine contains two conserved glycines of which at least one is present in most EGF-like domains; a subset of these bind calcium | Back alignment and domain information |
|---|
| >cd00053 EGF Epidermal growth factor domain, found in epidermal growth factor (EGF) presents in a large number of proteins, mostly animal; the list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied; the functional significance of EGF-like domains in what appear to be unrelated proteins is not yet clear; a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase); the domain includes six cysteine residues which have been shown to be involved in disulfide bonds; the main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet; Subdomains between the conserved cysteines vary in length; the region between the 5th and 6th cysteine contains two conserved glycines of which at least one is present in most EGF-like domains; a subset of these bind calcium | Back alignment and domain information |
|---|
| >smart00181 EGF Epidermal growth factor-like domain | Back alignment and domain information |
|---|
| >smart00181 EGF Epidermal growth factor-like domain | Back alignment and domain information |
|---|
| >KOG1218|consensus | Back alignment and domain information |
|---|
| >PF14670 FXa_inhibition: Coagulation Factor Xa inhibitory site; PDB: 3Q3K_B 1NFY_B 1LQD_A 1G2L_B 1IQF_L 2UWP_B 2VH6_B 3KQC_L 2P93_L 2BQW_A | Back alignment and domain information |
|---|
| >KOG1218|consensus | Back alignment and domain information |
|---|
| >PF12661 hEGF: Human growth factor-like EGF; PDB: 2YGQ_A 2E26_A 3A7Q_A 2YGP_A 2YGO_A 1HRE_A 1HAE_A 1HAF_A 1HRF_A | Back alignment and domain information |
|---|
| >PF07974 EGF_2: EGF-like domain; InterPro: IPR013111 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins | Back alignment and domain information |
|---|
| >cd01475 vWA_Matrilin VWA_Matrilin: In cartilaginous plate, extracellular matrix molecules mediate cell-matrix and matrix-matrix interactions thereby providing tissue integrity | Back alignment and domain information |
|---|
| >KOG3514|consensus | Back alignment and domain information |
|---|
| >KOG3512|consensus | Back alignment and domain information |
|---|
| >PF00683 TB: TB domain; InterPro: IPR002212 Transforming growth factor beta (TGF-beta)-binding protein-like (TB) domain comes from human fibrillin-1[] | Back alignment and domain information |
|---|
| >PF07974 EGF_2: EGF-like domain; InterPro: IPR013111 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins | Back alignment and domain information |
|---|
| >KOG3516|consensus | Back alignment and domain information |
|---|
| >PF12946 EGF_MSP1_1: MSP1 EGF domain 1; InterPro: IPR024730 This EGF-like domain is found at the C terminus of the malaria parasite MSP1 protein | Back alignment and domain information |
|---|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1290 | ||||
| 2rhp_A | 622 | The Thrombospondin-1 Polymorphism Asn700ser Associa | 1e-102 | ||
| 2rhp_A | 622 | The Thrombospondin-1 Polymorphism Asn700ser Associa | 7e-14 | ||
| 1yo8_A | 634 | Structure Of The C-Terminal Domain Of Human Thrombo | 1e-101 | ||
| 1yo8_A | 634 | Structure Of The C-Terminal Domain Of Human Thrombo | 4e-13 | ||
| 3fby_A | 551 | The Crystal Structure Of The Signature Domain Of Ca | 3e-98 | ||
| 3fby_A | 551 | The Crystal Structure Of The Signature Domain Of Ca | 1e-18 | ||
| 1ux6_A | 350 | Structure Of A Thrombospondin C-Terminal Fragment R | 3e-80 | ||
| 1ux6_A | 350 | Structure Of A Thrombospondin C-Terminal Fragment R | 5e-14 |
| >pdb|2RHP|A Chain A, The Thrombospondin-1 Polymorphism Asn700ser Associated With Cornoary Artery Disease Causes Local And Long-Ranging Changes In Protein Structure Length = 622 | Back alignment and structure |
|
| >pdb|2RHP|A Chain A, The Thrombospondin-1 Polymorphism Asn700ser Associated With Cornoary Artery Disease Causes Local And Long-Ranging Changes In Protein Structure Length = 622 | Back alignment and structure |
| >pdb|1YO8|A Chain A, Structure Of The C-Terminal Domain Of Human Thrombospondin-2 Length = 634 | Back alignment and structure |
| >pdb|1YO8|A Chain A, Structure Of The C-Terminal Domain Of Human Thrombospondin-2 Length = 634 | Back alignment and structure |
| >pdb|3FBY|A Chain A, The Crystal Structure Of The Signature Domain Of Cartilage Oligomeric Matrix Protein. Length = 551 | Back alignment and structure |
| >pdb|3FBY|A Chain A, The Crystal Structure Of The Signature Domain Of Cartilage Oligomeric Matrix Protein. Length = 551 | Back alignment and structure |
| >pdb|1UX6|A Chain A, Structure Of A Thrombospondin C-Terminal Fragment Reveals A Novel Calcium Core In The Type 3 Repeats Length = 350 | Back alignment and structure |
| >pdb|1UX6|A Chain A, Structure Of A Thrombospondin C-Terminal Fragment Reveals A Novel Calcium Core In The Type 3 Repeats Length = 350 | Back alignment and structure |
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3fby_A COMP, cartilage oligomeric matrix protein; signature domain, cell adhesion, disease mutation, dwarfism, EGF-like domain, glycoprotein, secreted; HET: NAG MAN; 3.15A {Homo sapiens} Length = 551 | Back alignment and structure |
|---|
Score = 386 bits (993), Expect = e-121
Identities = 239/460 (51%), Positives = 279/460 (60%), Gaps = 24/460 (5%)
Query: 687 SVRCDDIPEHPYYRCGSCPEGTTGNGTRCHDIDEDNCVH---IPNSGQEDADEDNIGDIC 743
P C E R V D D D D
Sbjct: 12 VWWNSAQRFCPDGSPSECHEHADCVLERDGSRSCVCAVGWAGNGILCGRDTDLDGFPDEK 71
Query: 744 DDDADNDGILNPSDNCPYVHNPDQLDSDQDGMRDRRLGDACDNCP--------TDNCPYV 795
+ DNC V N Q D D+DG +GDACD DNCP V
Sbjct: 72 LRCPERQCR---KDNCVTVPNSGQEDVDRDG-----IGDACDPDADGDGVPNEKDNCPLV 123
Query: 796 HNPDQLDSDQDGMRDRRLGDACDNCPTVPNVDQTDTDNDGTGDACDNDMDNDGINNHADN 855
NPDQ ++D+D GDACDNC + N DQ DTD DG GDACD+D+D D I N ADN
Sbjct: 124 RNPDQRNTDEDK-----WGDACDNCRSQKNDDQKDTDQDGRGDACDDDIDGDRIRNQADN 178
Query: 856 CPRNANPDQRDSDHDGIGDACDNCPRVSNPEQTDSNSNHIGDVCDSGVDTDHDGVPDPMD 915
CPR N DQ+DSD DGIGDACDNCP+ SNP+Q D + + +GD CDS D D DG D D
Sbjct: 179 CPRVPNSDQKDSDGDGIGDACDNCPQKSNPDQADVDHDFVGDACDSDQDQDGDGHQDSRD 238
Query: 916 NCPKVANPNQLDNDRDGKGDECDPDLDGDGISNDEDNCRLIYNPNQDDSDGDGVGNVCDK 975
NCP V N Q D+D DG+GD CD D D DG+ + DNCRL+ NP Q+D+D DGVG+VC
Sbjct: 239 NCPTVPNSAQEDSDHDGQGDACDDDDDNDGVPDSRDNCRLVPNPGQEDADRDGVGDVCQD 298
Query: 976 DFDKDGTPDVSDVCPNNSLVYRTDFRRYTTVILDPQGTSQIDPHWVIYNHGAEILQTMNS 1035
DFD D D DVCP N+ V TDFR + TV+LDP+G +QIDP+WV+ N G EI+QTMNS
Sbjct: 299 DFDADKVVDKIDVCPENAEVTLTDFRAFQTVVLDPEGDAQIDPNWVVLNQGREIVQTMNS 358
Query: 1036 DPGLAIGQDKFSGVDFEGTFFVDTDIDDDYAGFVFSYQSSQKFYVMMWKKNSQVYWQTTP 1095
DPGLA+G F+GVDFEGTF V+T DDDYAGF+F YQ S FYV+MWK+ Q YWQ P
Sbjct: 359 DPGLAVGYTAFNGVDFEGTFHVNTVTDDDYAGFIFGYQDSSSFYVVMWKQMEQTYWQANP 418
Query: 1096 FRAVAEPGIQLKVVDSATGPGTMLRNSLWHTGDTENQCDL 1135
FRAVAEPGIQLK V S+TGPG LRN+LWHTGDTE+Q L
Sbjct: 419 FRAVAEPGIQLKAVKSSTGPGEQLRNALWHTGDTESQVRL 458
|
| >3fby_A COMP, cartilage oligomeric matrix protein; signature domain, cell adhesion, disease mutation, dwarfism, EGF-like domain, glycoprotein, secreted; HET: NAG MAN; 3.15A {Homo sapiens} Length = 551 | Back alignment and structure |
|---|
| >3fby_A COMP, cartilage oligomeric matrix protein; signature domain, cell adhesion, disease mutation, dwarfism, EGF-like domain, glycoprotein, secreted; HET: NAG MAN; 3.15A {Homo sapiens} Length = 551 | Back alignment and structure |
|---|
| >3fby_A COMP, cartilage oligomeric matrix protein; signature domain, cell adhesion, disease mutation, dwarfism, EGF-like domain, glycoprotein, secreted; HET: NAG MAN; 3.15A {Homo sapiens} Length = 551 | Back alignment and structure |
|---|
| >3fby_A COMP, cartilage oligomeric matrix protein; signature domain, cell adhesion, disease mutation, dwarfism, EGF-like domain, glycoprotein, secreted; HET: NAG MAN; 3.15A {Homo sapiens} Length = 551 | Back alignment and structure |
|---|
| >3fby_A COMP, cartilage oligomeric matrix protein; signature domain, cell adhesion, disease mutation, dwarfism, EGF-like domain, glycoprotein, secreted; HET: NAG MAN; 3.15A {Homo sapiens} Length = 551 | Back alignment and structure |
|---|
| >3fby_A COMP, cartilage oligomeric matrix protein; signature domain, cell adhesion, disease mutation, dwarfism, EGF-like domain, glycoprotein, secreted; HET: NAG MAN; 3.15A {Homo sapiens} Length = 551 | Back alignment and structure |
|---|
| >3fby_A COMP, cartilage oligomeric matrix protein; signature domain, cell adhesion, disease mutation, dwarfism, EGF-like domain, glycoprotein, secreted; HET: NAG MAN; 3.15A {Homo sapiens} Length = 551 | Back alignment and structure |
|---|
| >1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* Length = 634 | Back alignment and structure |
|---|
| >1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* Length = 634 | Back alignment and structure |
|---|
| >1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* Length = 634 | Back alignment and structure |
|---|
| >1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* Length = 634 | Back alignment and structure |
|---|
| >1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* Length = 634 | Back alignment and structure |
|---|
| >1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* Length = 634 | Back alignment and structure |
|---|
| >1ux6_A Thrombospondin-1; extracellular matrix, calcium binding, L-type lectin, glycoprotein, cell adhesion, calcium-binding, heparin- binding; 1.9A {Homo sapiens} SCOP: b.29.1.16 g.75.1.1 Length = 350 | Back alignment and structure |
|---|
| >1ux6_A Thrombospondin-1; extracellular matrix, calcium binding, L-type lectin, glycoprotein, cell adhesion, calcium-binding, heparin- binding; 1.9A {Homo sapiens} SCOP: b.29.1.16 g.75.1.1 Length = 350 | Back alignment and structure |
|---|
| >1ux6_A Thrombospondin-1; extracellular matrix, calcium binding, L-type lectin, glycoprotein, cell adhesion, calcium-binding, heparin- binding; 1.9A {Homo sapiens} SCOP: b.29.1.16 g.75.1.1 Length = 350 | Back alignment and structure |
|---|
| >1ux6_A Thrombospondin-1; extracellular matrix, calcium binding, L-type lectin, glycoprotein, cell adhesion, calcium-binding, heparin- binding; 1.9A {Homo sapiens} SCOP: b.29.1.16 g.75.1.1 Length = 350 | Back alignment and structure |
|---|
| >1ux6_A Thrombospondin-1; extracellular matrix, calcium binding, L-type lectin, glycoprotein, cell adhesion, calcium-binding, heparin- binding; 1.9A {Homo sapiens} SCOP: b.29.1.16 g.75.1.1 Length = 350 | Back alignment and structure |
|---|
| >1ux6_A Thrombospondin-1; extracellular matrix, calcium binding, L-type lectin, glycoprotein, cell adhesion, calcium-binding, heparin- binding; 1.9A {Homo sapiens} SCOP: b.29.1.16 g.75.1.1 Length = 350 | Back alignment and structure |
|---|
| >1ux6_A Thrombospondin-1; extracellular matrix, calcium binding, L-type lectin, glycoprotein, cell adhesion, calcium-binding, heparin- binding; 1.9A {Homo sapiens} SCOP: b.29.1.16 g.75.1.1 Length = 350 | Back alignment and structure |
|---|
| >1ux6_A Thrombospondin-1; extracellular matrix, calcium binding, L-type lectin, glycoprotein, cell adhesion, calcium-binding, heparin- binding; 1.9A {Homo sapiens} SCOP: b.29.1.16 g.75.1.1 Length = 350 | Back alignment and structure |
|---|
| >1ux6_A Thrombospondin-1; extracellular matrix, calcium binding, L-type lectin, glycoprotein, cell adhesion, calcium-binding, heparin- binding; 1.9A {Homo sapiens} SCOP: b.29.1.16 g.75.1.1 Length = 350 | Back alignment and structure |
|---|
| >2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A Length = 143 | Back alignment and structure |
|---|
| >2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A Length = 143 | Back alignment and structure |
|---|
| >1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A Length = 162 | Back alignment and structure |
|---|
| >1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A Length = 162 | Back alignment and structure |
|---|
| >1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A Length = 162 | Back alignment and structure |
|---|
| >1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A Length = 162 | Back alignment and structure |
|---|
| >1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A Length = 162 | Back alignment and structure |
|---|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 Length = 86 | Back alignment and structure |
|---|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 Length = 86 | Back alignment and structure |
|---|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 Length = 86 | Back alignment and structure |
|---|
| >2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens} Length = 147 | Back alignment and structure |
|---|
| >2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens} Length = 147 | Back alignment and structure |
|---|
| >2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens} Length = 147 | Back alignment and structure |
|---|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A Length = 82 | Back alignment and structure |
|---|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A Length = 82 | Back alignment and structure |
|---|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A Length = 82 | Back alignment and structure |
|---|
| >2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* Length = 135 | Back alignment and structure |
|---|
| >2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* Length = 135 | Back alignment and structure |
|---|
| >2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* Length = 135 | Back alignment and structure |
|---|
| >2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* Length = 135 | Back alignment and structure |
|---|
| >1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Length = 195 | Back alignment and structure |
|---|
| >1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Length = 195 | Back alignment and structure |
|---|
| >1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Length = 195 | Back alignment and structure |
|---|
| >2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A Length = 107 | Back alignment and structure |
|---|
| >2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A Length = 107 | Back alignment and structure |
|---|
| >1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} Length = 87 | Back alignment and structure |
|---|
| >1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A Length = 118 | Back alignment and structure |
|---|
| >1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A Length = 118 | Back alignment and structure |
|---|
| >4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} Length = 143 | Back alignment and structure |
|---|
| >4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} Length = 143 | Back alignment and structure |
|---|
| >4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} Length = 143 | Back alignment and structure |
|---|
| >1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* Length = 114 | Back alignment and structure |
|---|
| >1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* Length = 114 | Back alignment and structure |
|---|
| >1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* Length = 114 | Back alignment and structure |
|---|
| >1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* Length = 146 | Back alignment and structure |
|---|
| >1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* Length = 146 | Back alignment and structure |
|---|
| >1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* Length = 146 | Back alignment and structure |
|---|
| >1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A Length = 186 | Back alignment and structure |
|---|
| >2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... Length = 134 | Back alignment and structure |
|---|
| >2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... Length = 134 | Back alignment and structure |
|---|
| >2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... Length = 134 | Back alignment and structure |
|---|
| >2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ... Length = 142 | Back alignment and structure |
|---|
| >2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ... Length = 142 | Back alignment and structure |
|---|
| >4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus} Length = 525 | Back alignment and structure |
|---|
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* Length = 423 | Back alignment and structure |
|---|
| >1apq_A Complement protease C1R; EGF, calcium binding, serine protease; NMR {Homo sapiens} SCOP: g.3.11.1 Length = 53 | Back alignment and structure |
|---|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1290 | |||
| 1yo8_A | 634 | Thrombospondin-2; EGF, Ca(2+)-binding domains, lec | 100.0 | |
| 3fby_A | 551 | COMP, cartilage oligomeric matrix protein; signatu | 100.0 | |
| 3fby_A | 551 | COMP, cartilage oligomeric matrix protein; signatu | 100.0 | |
| 1yo8_A | 634 | Thrombospondin-2; EGF, Ca(2+)-binding domains, lec | 100.0 | |
| 1ux6_A | 350 | Thrombospondin-1; extracellular matrix, calcium bi | 100.0 | |
| 1ux6_A | 350 | Thrombospondin-1; extracellular matrix, calcium bi | 100.0 | |
| 4fbr_A | 267 | Lectin, myxobacterial hemagglutinin; beta-barrel, | 99.8 | |
| 1z1y_A | 186 | Ookinete surface protein PVS25; four EGF-like doma | 99.78 | |
| 1z1y_A | 186 | Ookinete surface protein PVS25; four EGF-like doma | 99.72 | |
| 2vj3_A | 135 | Neurogenic locus notch homolog protein 1; transcri | 99.72 | |
| 4fbr_A | 267 | Lectin, myxobacterial hemagglutinin; beta-barrel, | 99.7 | |
| 2vj3_A | 135 | Neurogenic locus notch homolog protein 1; transcri | 99.68 | |
| 2ygq_A | 324 | WIF-1, WNT inhibitory factor 1; signaling protein, | 99.57 | |
| 2ygq_A | 324 | WIF-1, WNT inhibitory factor 1; signaling protein, | 99.56 | |
| 4d90_A | 143 | EGF-like repeat and discoidin I-like domain-conta | 99.56 | |
| 1uzk_A | 162 | Fibrillin-1; glycoprotein, extra-cellular matrix, | 99.55 | |
| 4d90_A | 143 | EGF-like repeat and discoidin I-like domain-conta | 99.54 | |
| 1uzk_A | 162 | Fibrillin-1; glycoprotein, extra-cellular matrix, | 99.54 | |
| 2bou_A | 143 | EGF-like module containing mucin-like hormone rece | 99.5 | |
| 2bou_A | 143 | EGF-like module containing mucin-like hormone rece | 99.5 | |
| 3fcs_B | 690 | Integrin beta-3; beta propeller, rossmann fold, EG | 99.45 | |
| 2vj2_A | 169 | Jagged-1; signalling, polymorphism, glycoprotein, | 99.43 | |
| 2vj2_A | 169 | Jagged-1; signalling, polymorphism, glycoprotein, | 99.41 | |
| 3fcs_B | 690 | Integrin beta-3; beta propeller, rossmann fold, EG | 99.4 | |
| 1dx5_I | 118 | Thrombomodulin; serine proteinase, EGF-like domain | 99.33 | |
| 2w86_A | 147 | Fibrillin-1, fibrillin1; phosphoprotein, EGF-like | 99.3 | |
| 1dx5_I | 118 | Thrombomodulin; serine proteinase, EGF-like domain | 99.28 | |
| 2w86_A | 147 | Fibrillin-1, fibrillin1; phosphoprotein, EGF-like | 99.2 | |
| 1emn_A | 82 | Fibrillin; extracellular matrix, calcium-binding, | 99.14 | |
| 1tpg_A | 91 | T-plasminogen activator F1-G; plasminogen activati | 99.1 | |
| 1tpg_A | 91 | T-plasminogen activator F1-G; plasminogen activati | 99.07 | |
| 1emn_A | 82 | Fibrillin; extracellular matrix, calcium-binding, | 99.06 | |
| 3k6s_B | 687 | Integrin beta-2; cell receptor, adhesion molecule, | 99.05 | |
| 3k6s_B | 687 | Integrin beta-2; cell receptor, adhesion molecule, | 99.02 | |
| 1x7a_L | 146 | Coagulation factor IX, light chain; inhibition, bl | 99.0 | |
| 2gy5_A | 423 | Angiopoietin-1 receptor; ligand-binding domain, tr | 98.99 | |
| 1lmj_A | 86 | Fibrillin 1; EGF, calcium, microfibril, neonatal, | 98.97 | |
| 2c4f_L | 142 | Coagulation factor VII precursor; blood coagulatio | 98.97 | |
| 1lmj_A | 86 | Fibrillin 1; EGF, calcium, microfibril, neonatal, | 98.92 | |
| 1x7a_L | 146 | Coagulation factor IX, light chain; inhibition, bl | 98.91 | |
| 4aqs_A | 525 | Laminin subunit beta-1; cell adhesion; HET: NAG BM | 98.89 | |
| 1aut_L | 114 | Activated protein C; serine proteinase, plasma cal | 98.89 | |
| 1n7d_A | 699 | LDL receptor, low-density lipoprotein receptor; fa | 98.87 | |
| 1nfu_B | 195 | Coagulation factor XA, light chain; hydrolase; HET | 98.86 | |
| 1z6c_A | 87 | Vitamin K-dependent protein S; EGF module, blood c | 98.85 | |
| 1aut_L | 114 | Activated protein C; serine proteinase, plasma cal | 98.85 | |
| 1z6c_A | 87 | Vitamin K-dependent protein S; EGF module, blood c | 98.84 | |
| 2vh0_B | 134 | Activated factor XA light chain; serine protease, | 98.81 | |
| 2c4f_L | 142 | Coagulation factor VII precursor; blood coagulatio | 98.8 | |
| 2gy5_A | 423 | Angiopoietin-1 receptor; ligand-binding domain, tr | 98.77 | |
| 1nfu_B | 195 | Coagulation factor XA, light chain; hydrolase; HET | 98.75 | |
| 3h5c_B | 317 | Vitamin K-dependent protein Z; protein Z-protein Z | 98.74 | |
| 1n7d_A | 699 | LDL receptor, low-density lipoprotein receptor; fa | 98.74 | |
| 4aqs_A | 525 | Laminin subunit beta-1; cell adhesion; HET: NAG BM | 98.72 | |
| 2w2n_E | 107 | LDL receptor, low-density lipoprotein receptor; hy | 98.71 | |
| 3m0c_C | 791 | LDL receptor, low-density lipoprotein receptor; pr | 98.68 | |
| 2vh0_B | 134 | Activated factor XA light chain; serine protease, | 98.67 | |
| 2w2n_E | 107 | LDL receptor, low-density lipoprotein receptor; hy | 98.66 | |
| 3h5c_B | 317 | Vitamin K-dependent protein Z; protein Z-protein Z | 98.64 | |
| 3m0c_C | 791 | LDL receptor, low-density lipoprotein receptor; pr | 98.44 | |
| 3p5b_L | 400 | Low density lipoprotein receptor variant; B-propel | 98.23 | |
| 3p5b_L | 400 | Low density lipoprotein receptor variant; B-propel | 98.21 | |
| 3v65_B | 386 | Low-density lipoprotein receptor-related protein; | 98.15 | |
| 3v65_B | 386 | Low-density lipoprotein receptor-related protein; | 98.13 | |
| 1klo_A | 162 | Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: | 98.12 | |
| 3u7u_G | 55 | Neuregulin 1; signaling protein, transferase-trans | 97.94 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 97.73 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 97.71 | |
| 3u7u_G | 55 | Neuregulin 1; signaling protein, transferase-trans | 97.63 | |
| 1klo_A | 162 | Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: | 97.61 | |
| 2p28_B | 217 | Integrin beta-2; hybrid domain, PSI domain, I-EGF | 97.59 | |
| 2p28_B | 217 | Integrin beta-2; hybrid domain, PSI domain, I-EGF | 97.57 | |
| 2k2s_B | 61 | Micronemal protein 6; microneme protein complex, c | 97.54 | |
| 1a3p_A | 45 | Epidermal growth factor; disulfide connectivities, | 97.45 | |
| 2k2s_B | 61 | Micronemal protein 6; microneme protein complex, c | 97.44 | |
| 1hae_A | 63 | Heregulin-alpha; growth factor; NMR {Homo sapiens} | 97.38 | |
| 1a3p_A | 45 | Epidermal growth factor; disulfide connectivities, | 97.35 | |
| 2wg3_C | 463 | Hedgehog-interacting protein; lipoprotein, develop | 97.32 | |
| 1egf_A | 53 | Epidermal growth factor; NMR {Mus musculus} SCOP: | 97.32 | |
| 1egf_A | 53 | Epidermal growth factor; NMR {Mus musculus} SCOP: | 97.24 | |
| 2wg3_C | 463 | Hedgehog-interacting protein; lipoprotein, develop | 97.21 | |
| 1hae_A | 63 | Heregulin-alpha; growth factor; NMR {Homo sapiens} | 97.14 | |
| 3ca7_A | 52 | Protein spitz; argos, EGF, developmental protein, | 97.01 | |
| 3zyj_B | 426 | Netrin-G1; cell adhesion, synapse; HET: NAG BMA MA | 97.0 | |
| 1kli_L | 69 | Factor VIIA; extrinsic coagulation pathway, serine | 96.87 | |
| 2jkh_L | 55 | Factor X light chain; plasma, calcium, zymogen, se | 96.85 | |
| 1k36_A | 46 | Epiregulin; EGF-like fold, hormone/growth factor c | 96.79 | |
| 3zyj_B | 426 | Netrin-G1; cell adhesion, synapse; HET: NAG BMA MA | 96.72 | |
| 3ca7_A | 52 | Protein spitz; argos, EGF, developmental protein, | 96.69 | |
| 1k36_A | 46 | Epiregulin; EGF-like fold, hormone/growth factor c | 96.57 | |
| 1apq_A | 53 | Complement protease C1R; EGF, calcium binding, ser | 96.55 | |
| 1gl4_A | 285 | Nidogen-1, entactin; immunoglobulin-like domain, e | 96.53 | |
| 2kl7_A | 71 | Fibulin-4; secreted, calcium, disease mutation, di | 96.45 | |
| 1g1s_A | 162 | P-selectin; selectin, lectin, EGF, sulphated, SLEX | 96.27 | |
| 1kig_L | 51 | Factor XA; glycoprotein, serine protease, plasma, | 96.11 | |
| 1ob1_C | 99 | Major merozoite surface protein; immune system, im | 96.09 | |
| 1nql_B | 53 | Epidermal growth factor; cell surface receptor, ty | 96.06 | |
| 1nql_B | 53 | Epidermal growth factor; cell surface receptor, ty | 96.03 | |
| 1gl4_A | 285 | Nidogen-1, entactin; immunoglobulin-like domain, e | 95.99 | |
| 1n1i_A | 105 | Merozoite surface protein-1; MSP1, malaria, surfac | 95.93 | |
| 2jkh_L | 55 | Factor X light chain; plasma, calcium, zymogen, se | 95.89 | |
| 1g1s_A | 162 | P-selectin; selectin, lectin, EGF, sulphated, SLEX | 95.85 | |
| 2kl7_A | 71 | Fibulin-4; secreted, calcium, disease mutation, di | 95.8 | |
| 1ob1_C | 99 | Major merozoite surface protein; immune system, im | 95.75 | |
| 1kig_L | 51 | Factor XA; glycoprotein, serine protease, plasma, | 95.61 | |
| 1n1i_A | 105 | Merozoite surface protein-1; MSP1, malaria, surfac | 95.55 | |
| 1kli_L | 69 | Factor VIIA; extrinsic coagulation pathway, serine | 95.54 | |
| 1apq_A | 53 | Complement protease C1R; EGF, calcium binding, ser | 95.53 | |
| 2bz6_L | 53 | Blood coagulation factor VIIA; serine protease, en | 95.51 | |
| 2fd6_A | 122 | Urokinase-type plasminogen activator; UPAR, ATF, A | 95.47 | |
| 2fd6_A | 122 | Urokinase-type plasminogen activator; UPAR, ATF, A | 94.79 | |
| 3ltf_D | 58 | Protein spitz; receptor-ligand complex ectodomain | 94.31 | |
| 2wph_E | 59 | Coagulation factor IXA light chain; serine proteas | 94.28 | |
| 3ltf_D | 58 | Protein spitz; receptor-ligand complex ectodomain | 93.76 | |
| 2bz6_L | 53 | Blood coagulation factor VIIA; serine protease, en | 93.59 | |
| 1q4g_A | 553 | Prostaglandin G/H synthase 1; cyclooxygenase, non- | 93.03 | |
| 1q4g_A | 553 | Prostaglandin G/H synthase 1; cyclooxygenase, non- | 92.98 | |
| 3nt1_A | 587 | Prostaglandin-endoperoxide synthase 2; prostagland | 92.32 | |
| 3nt1_A | 587 | Prostaglandin-endoperoxide synthase 2; prostagland | 92.2 | |
| 3cfw_A | 164 | L-selectin; EGF, cell adhesion, EGF-like domain, g | 91.11 | |
| 1szb_A | 170 | Mannose binding lectin-associated serine protease- | 90.88 | |
| 2i9a_A | 145 | Urokinase-type plasminogen activator; growth facto | 90.72 | |
| 3cfw_A | 164 | L-selectin; EGF, cell adhesion, EGF-like domain, g | 89.67 | |
| 1szb_A | 170 | Mannose binding lectin-associated serine protease- | 89.14 | |
| 2wph_E | 59 | Coagulation factor IXA light chain; serine proteas | 88.4 | |
| 3e50_C | 50 | Protransforming growth factor alpha; IDE, TGF-alph | 88.11 | |
| 1nzi_A | 159 | Complement C1S component; calcium, innate immunity | 86.26 | |
| 3f1s_B | 283 | Vitamin K-dependent protein Z; PZ, ZPI, complex, s | 86.1 | |
| 3e50_C | 50 | Protransforming growth factor alpha; IDE, TGF-alph | 86.01 | |
| 1g1t_A | 157 | E-selectin; EGF, adhesion molecule, SLEX, immune s | 85.59 | |
| 2i9a_A | 145 | Urokinase-type plasminogen activator; growth facto | 84.89 | |
| 2rnl_A | 50 | Amphiregulin; AR, colorectum cell-derived growth f | 84.52 | |
| 1iox_A | 50 | Betacellulin; EGF-like fold, hormone/growth factor | 84.45 | |
| 2rnl_A | 50 | Amphiregulin; AR, colorectum cell-derived growth f | 84.32 | |
| 1iox_A | 50 | Betacellulin; EGF-like fold, hormone/growth factor | 83.72 | |
| 1xdt_R | 79 | Hbegf, heparin-binding epidermal growth factor; co | 83.42 | |
| 3v64_C | 349 | Agrin; beta propeller, laminin-G, signaling, prote | 83.41 | |
| 4aqt_A | 375 | Laminin subunit gamma-1; cell adhesion; HET: NAG B | 82.87 | |
| 1g1t_A | 157 | E-selectin; EGF, adhesion molecule, SLEX, immune s | 82.83 | |
| 2ygo_A | 188 | WIF-1, WNT inhibitory factor 1; signaling protein, | 81.76 | |
| 1xdt_R | 79 | Hbegf, heparin-binding epidermal growth factor; co | 81.52 | |
| 3asi_A | 410 | Neurexin-1-alpha; beta-sandwich, cell adhesion, sy | 81.28 |
| >1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-110 Score=1028.32 Aligned_cols=523 Identities=50% Similarity=0.954 Sum_probs=489.6
Q ss_pred CCCCCCCCCCCCceeccCCCC-CccccCCCCccCCCccccCCCCcCCCC--CCCCC---ccccCCCCcc---cCCcccee
Q psy620 588 PTCATDNPCFPGVECRDTREG-PRCMRCPDGYVGDGIHCKPGVTCNMRP--CFQGV---QCFDTVFNAS---IRLKVTHV 658 (1290)
Q Consensus 588 ~~C~~~nPC~~g~~C~~~~~g-~~Cg~Cp~G~~Gdg~~C~dideC~~~p--C~~g~---~Cvnt~~g~~---C~~g~~g~ 658 (1290)
.+|+ ++||+++++|+++..+ |+|+.|++||+|++.+|++|+||+.+| |.+++ +|+|+.++|+ |++||+|.
T Consensus 4 DeC~-~nPC~~gg~C~n~~~Gsy~C~~C~~GytGdg~~CeDiDEC~~~p~~C~~gg~~~~CvNt~gsY~C~~C~~Gy~G~ 82 (634)
T 1yo8_A 4 DGCL-SNPCFPGAQCSSFPDGSWSCGFCPVGFLGNGTHCEDLDECALVPDICFSTSKVPRCVNTQPGFHCLPCPPRYRGN 82 (634)
T ss_dssp CGGG-GCCSCTTCCEEECTTSCEEECCCCTTBCSCSSSCCBCCTTTTSCCCSCCCSSSCCEEECSSSEEECCCCTTEEEC
T ss_pred cccC-CCCCCCCCEEecCCCCCeECCcCCCccCCCCCCccccccccCCCCcccCCccccceeeccCceecccCCCCcccC
Confidence 3565 7999999999999976 999889999999999999999999988 99999 9999998874 67888765
Q ss_pred eecc------cCCccccccchhhcccccCcCCCCCCccCCCCCC----CCCccCCCCCCCCCCCCccC---CCCCCC---
Q psy620 659 VLVR------LDTQEMVRDVNALVDVRATRALKASVRCDDIPEH----PYYRCGSCPEGTTGNGTRCH---DIDEDN--- 722 (1290)
Q Consensus 659 ~~~~------~~~~~~C~di~eC~~~~~~~~C~~~~~C~~~~~~----g~y~C~~C~~Gy~Gng~~C~---~~~~~~--- 722 (1290)
.... ....+.|.+|+||.. ..++|.+++.| ++.. ++|+|. |++||+|+|..|+ +++|++
T Consensus 83 ~c~g~g~~~~~~dg~~C~dideC~~--~~~pC~~~~~C--vnt~~~~~GsY~C~-C~~Gy~GdG~~Ce~d~DiDeC~~~~ 157 (634)
T 1yo8_A 83 QPVGVGLEAAKTEKQVCEPENPCKD--KTHNCHKHAEC--IYLGHFSDPMYKCE-CQTGYAGDGLICGEDSDLDGWPNLN 157 (634)
T ss_dssp CCEESSSHHHHSCCCCEEECCTTTT--TCCCCCTTEEE--EECCTTCSSSEEEE-ECTTEEESSSSEEECTTSSSSCSSC
T ss_pred ccccccccccccCCCcccccccccC--CCcccccCccc--cccccccccceeee-ccCCccccCcccccccCcccccCCC
Confidence 4321 123456999999975 34799999999 4455 899997 9999999999996 666542
Q ss_pred ---------------CCCCCCCCCccCCCCCCCCccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccCCCCCCCC
Q psy620 723 ---------------CVHIPNSGQEDADEDNIGDICDDDADNDGILNPSDNCPYVHNPDQLDSDQDGMRDRRLGDACDNC 787 (1290)
Q Consensus 723 ---------------C~~~p~~~~~d~d~dg~~d~~d~D~D~DG~~d~~~~c~~~~~~~~~D~D~DG~~D~~~~~~~~~~ 787 (1290)
|...+++.|+|.|++|++++|+.|+|+|||+|..++|+..+|+.+.|+|+|||+|
T Consensus 158 ~~C~~~~~y~C~~dnC~~~pns~q~D~D~dG~Gd~Cd~D~D~DGi~d~~d~c~~~~n~~~~D~D~Dgv~D---------- 227 (634)
T 1yo8_A 158 LVCATNATYHCIKDNCPHLPNSGQEDFDKDGIGDACDDDDDNDGVTDEKDNCQLLFNPRQADYDKDEVGD---------- 227 (634)
T ss_dssp CTTTTTCSSSCSCCSSTTSCCTTCCCSSCSSSCTTTCSSTTSSSSCTTTCSSTTSCCTTCCCSSSSSSCG----------
T ss_pred CcccCCCCccccccccccccCcccCCcccccccccccccccccCCcccccccccccccccccccCCCCCc----------
Confidence 7788899999999999999999999999999999999998888777777776654
Q ss_pred CCCCCCCCCCCCCCCCCCCCCccCcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcCCCCCCCCCCCCC
Q psy620 788 PTDNCPYVHNPDQLDSDQDGMRDRRLGDACDNCPTVPNVDQTDTDNDGTGDACDNDMDNDGINNHADNCPRNANPDQRDS 867 (1290)
Q Consensus 788 ~~~~c~~~~~~~~~D~D~DGi~D~~~~d~~d~c~~~~~~~~~D~D~DG~~D~~d~D~D~DGi~d~~d~c~~~~n~~~~D~ 867 (1290)
++|+||.++|+.|+|+|+|||+|+||.|+|+|||+|..|+||+.+|+.|.|+
T Consensus 228 ----------------------------~~D~cp~~~n~~~~D~D~DG~~D~~d~D~D~DGi~d~~D~cp~~~n~~~~D~ 279 (634)
T 1yo8_A 228 ----------------------------RCDNCPYVHNPAQIDTDNNGEGDACSVDIDGDDVFNERDNCPYVYNTDQRDT 279 (634)
T ss_dssp ----------------------------GGCSSTTSCCTTCCCTTCSSSCGGGCSSTTSSSSCTTTCSSTTSCCTTCCCT
T ss_pred ----------------------------ccccCCCCCCCCccCcCCCCCCCCCCCCCCCCCCCccccCCCCcCCCCCCCC
Confidence 3599999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccCCCCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q psy620 868 DHDGIGDACDNCPRVSNPEQTDSNSNHIGDVCDSGVDTDHDGVPDPMDNCPKVANPNQLDNDRDGKGDECDPDLDGDGIS 947 (1290)
Q Consensus 868 D~Dg~~D~~d~cp~~~n~~~~D~d~dg~~d~~d~~~D~D~DGi~d~~d~cp~~~n~~~~D~D~Dg~~D~~d~D~D~DGi~ 947 (1290)
|+|||+|++|+||.++|+.|.|+|+||++|+|+..+|+|+|||+|..|+||.++++.|.|+|+|||+|+|+.|+|+|||+
T Consensus 280 D~DGi~D~~D~cp~~~~~~~~D~D~DG~~D~cd~~~D~DgDGi~d~~D~cp~~~~~~~~D~D~DG~~D~cd~D~D~DGv~ 359 (634)
T 1yo8_A 280 DGDGVGDHCDNCPLVHNPDQTDVDNDLVGDQCDNNEDIDDDGHQNNQDNCPYISNANQADHDRDGQGDACDPDDDNDGVP 359 (634)
T ss_dssp TCSSSCGGGCSSTTSCCTTCCCTTSSSSCTTTCCCCCTTSSSSCGGGCSSTTSCCTTCCCTTCSSSCTTTCSCTTCSSSC
T ss_pred CCCCCCcccccccccCCCcccccCCCCCCccccCCCCcCcCCCccccccCCCCCCccccccCCCCCcccCCCccCCCCCC
Confidence 99999999999999999999999999999999988899999999999999999999999999999999999999999999
Q ss_pred CCCccccCcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccccccceeeecCCCCCcCCCCceeeccCCc
Q psy620 948 NDEDNCRLIYNPNQDDSDGDGVGNVCDKDFDKDGTPDVSDVCPNNSLVYRTDFRRYTTVILDPQGTSQIDPHWVIYNHGA 1027 (1290)
Q Consensus 948 d~~d~cp~~~n~~~~D~D~DG~~d~~d~D~D~DGi~d~~d~cp~~~~~~~~d~~~~~~~~~d~~g~~~~d~~~~v~~~g~ 1027 (1290)
|..|+||.++++.|+|+|+||++|+|+.|+|+|||||.+|+||+++.+.+++|+.|++|.|+++|.++.+|+|+++++|.
T Consensus 360 D~~D~cp~~~~~~~~D~D~DG~~d~cd~D~D~DGi~D~~D~cp~~~~~~~~d~~~~~~v~ld~~g~~~i~p~~~~~~~g~ 439 (634)
T 1yo8_A 360 DDRDNCRLVFNPDQEDLDGDGRGDICKDDFDNDNIPDIDDVCPENNAISETDFRNFQMVPLDPKGTTQIDPNWVIRHQGK 439 (634)
T ss_dssp GGGCTTTTSCCTTCCCTTCSSSCGGGSSCTTCSSSCGGGCSSTTCTTCCSCCCSSEEEEESSCCSSSCCCCCEEEEGGGT
T ss_pred CccccCCCCCCccccCcCCCCCCCCCCCCCCCCCCccccccCCCcCCcccccccccceEecCCCCCcccCccceeccCch
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eEEEeecCCCCcccccccccceeeecceeecccCCCCccceEeeeccCCcEEEEeccccceeeeeccccccccCCccEEE
Q psy620 1028 EILQTMNSDPGLAIGQDKFSGVDFEGTFFVDTDIDDDYAGFVFSYQSSQKFYVMMWKKNSQVYWQTTPFRAVAEPGIQLK 1107 (1290)
Q Consensus 1028 ~~~q~~~~dp~~~~g~~~~~~~d~~g~~~~~~~~d~~~~gfvf~yq~~~~f~~~~~~~~~~~~w~~~~f~~~~~~g~~~~ 1107 (1290)
||+|+|+++|+++||.++|++|+|+|||||++..+++|+||||+||++++|||||||+..|+||+.++|||+|++|||+|
T Consensus 440 ~i~~~~~~~P~~~~~~~~~~~v~~~g~~~v~~~~~dd~~g~~~g~~~~~~fy~~~~~~~~~~y~~~~~f~~~~~~~~~~~ 519 (634)
T 1yo8_A 440 ELVQTANSDPGIAVGFDEFGSVDFSGTFYVNTDRDDDYAGFVFGYQSSSRFYVVMWKQVTQTYWEDQPTRAYGYSGVSLK 519 (634)
T ss_dssp EEEECSCCSSEEEEEEEEESSEEEEEEEEECCSSCCCEEEEEEEEEETTEEEEEEEESSCEECSCCSSSCCEECSEEEEE
T ss_pred hhheehhcCCcceeccccccceeeeEEEEEecCCCCCceeEEEEEcCCCcEEEEEecccceeeecCCcceEEeeeeEEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EecCCCCCCcccccccccCCCcccccccCCCcCCCcccccCCCCcccC
Q psy620 1108 VVDSATGPGTMLRNSLWHTGDTENQCDLAEPCDPRVQCTNLFPGYRCD 1155 (1290)
Q Consensus 1108 ~~~~~~~~~~~~~~~~w~~~~~~~q~~~~w~~~~~~~~~~~~~~~~~~ 1155 (1290)
+|+|+||||++||++|||++.|.+||++||| ++++++|+....|+|.
T Consensus 520 ~~~s~~~pg~~l~~~~~~~~~~~~~~~~lw~-~~~~~~w~~~~~~~w~ 566 (634)
T 1yo8_A 520 VVNSTTGTGEHLRNALWHTGNTPGQVRTLWH-DPRNIGWKDYTAYRWH 566 (634)
T ss_dssp EEECSSCTTHHHHHHHHSSSCBTTTEEEEEE-CTTCCCCCTTCCEEEE
T ss_pred EeeccCCcchhhhhhccccCCCcchhhhhhc-CCCcCCCcCCccceeE
Confidence 9999999999999999999999999999999 9999999988888876
|
| >3fby_A COMP, cartilage oligomeric matrix protein; signature domain, cell adhesion, disease mutation, dwarfism, EGF-like domain, glycoprotein, secreted; HET: NAG MAN; 3.15A {Homo sapiens} | Back alignment and structure |
|---|
| >3fby_A COMP, cartilage oligomeric matrix protein; signature domain, cell adhesion, disease mutation, dwarfism, EGF-like domain, glycoprotein, secreted; HET: NAG MAN; 3.15A {Homo sapiens} | Back alignment and structure |
|---|
| >1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* | Back alignment and structure |
|---|
| >1ux6_A Thrombospondin-1; extracellular matrix, calcium binding, L-type lectin, glycoprotein, cell adhesion, calcium-binding, heparin- binding; 1.9A {Homo sapiens} SCOP: b.29.1.16 g.75.1.1 | Back alignment and structure |
|---|
| >1ux6_A Thrombospondin-1; extracellular matrix, calcium binding, L-type lectin, glycoprotein, cell adhesion, calcium-binding, heparin- binding; 1.9A {Homo sapiens} SCOP: b.29.1.16 g.75.1.1 | Back alignment and structure |
|---|
| >4fbr_A Lectin, myxobacterial hemagglutinin; beta-barrel, HIV-inactivating, carbohydrate binding protein; 1.60A {Myxococcus xanthus} PDB: 4fbv_A* | Back alignment and structure |
|---|
| >1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A | Back alignment and structure |
|---|
| >1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A | Back alignment and structure |
|---|
| >2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* | Back alignment and structure |
|---|
| >4fbr_A Lectin, myxobacterial hemagglutinin; beta-barrel, HIV-inactivating, carbohydrate binding protein; 1.60A {Myxococcus xanthus} PDB: 4fbv_A* | Back alignment and structure |
|---|
| >2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* | Back alignment and structure |
|---|
| >2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} | Back alignment and structure |
|---|
| >2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} | Back alignment and structure |
|---|
| >4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
| >1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A | Back alignment and structure |
|---|
| >4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
| >1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A | Back alignment and structure |
|---|
| >2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A | Back alignment and structure |
|---|
| >2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A | Back alignment and structure |
|---|
| >3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 4g1e_B* 3ije_B* 4g1m_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* | Back alignment and structure |
|---|
| >2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A | Back alignment and structure |
|---|
| >2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A | Back alignment and structure |
|---|
| >3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 4g1e_B* 3ije_B* 4g1m_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* | Back alignment and structure |
|---|
| >1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A | Back alignment and structure |
|---|
| >2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
| >1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A | Back alignment and structure |
|---|
| >2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A | Back alignment and structure |
|---|
| >1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A | Back alignment and structure |
|---|
| >1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A | Back alignment and structure |
|---|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A | Back alignment and structure |
|---|
| >3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* | Back alignment and structure |
|---|
| >3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* | Back alignment and structure |
|---|
| >1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* | Back alignment and structure |
|---|
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* | Back alignment and structure |
|---|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 | Back alignment and structure |
|---|
| >2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ... | Back alignment and structure |
|---|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 | Back alignment and structure |
|---|
| >1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* | Back alignment and structure |
|---|
| >4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus} | Back alignment and structure |
|---|
| >1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* | Back alignment and structure |
|---|
| >1n7d_A LDL receptor, low-density lipoprotein receptor; familial hypercholesterolemia, cholestero metabolism, lipid transport; HET: NAG BMA MAN KEG; 3.70A {Homo sapiens} SCOP: b.68.5.1 g.3.11.1 g.3.11.1 g.3.11.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 PDB: 2lgp_A 1xfe_A 1f5y_A 1ldl_A 1ldr_A 1d2j_A 1f8z_A | Back alignment and structure |
|---|
| >1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* | Back alignment and structure |
|---|
| >1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* | Back alignment and structure |
|---|
| >1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... | Back alignment and structure |
|---|
| >2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ... | Back alignment and structure |
|---|
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* | Back alignment and structure |
|---|
| >1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* | Back alignment and structure |
|---|
| >3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens} | Back alignment and structure |
|---|
| >1n7d_A LDL receptor, low-density lipoprotein receptor; familial hypercholesterolemia, cholestero metabolism, lipid transport; HET: NAG BMA MAN KEG; 3.70A {Homo sapiens} SCOP: b.68.5.1 g.3.11.1 g.3.11.1 g.3.11.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 PDB: 2lgp_A 1xfe_A 1f5y_A 1ldl_A 1ldr_A 1d2j_A 1f8z_A | Back alignment and structure |
|---|
| >4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus} | Back alignment and structure |
|---|
| >2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A | Back alignment and structure |
|---|
| >3m0c_C LDL receptor, low-density lipoprotein receptor; protein complex, beta propeller, cholesterol clearance, PCSK autocatalytic cleavage; 7.01A {Homo sapiens} | Back alignment and structure |
|---|
| >2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... | Back alignment and structure |
|---|
| >2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A | Back alignment and structure |
|---|
| >3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens} | Back alignment and structure |
|---|
| >3m0c_C LDL receptor, low-density lipoprotein receptor; protein complex, beta propeller, cholesterol clearance, PCSK autocatalytic cleavage; 7.01A {Homo sapiens} | Back alignment and structure |
|---|
| >3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L | Back alignment and structure |
|---|
| >3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L | Back alignment and structure |
|---|
| >3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus} | Back alignment and structure |
|---|
| >3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus} | Back alignment and structure |
|---|
| >1klo_A Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: g.3.11.2 g.3.11.2 g.3.11.2 PDB: 1npe_B 1tle_A | Back alignment and structure |
|---|
| >3u7u_G Neuregulin 1; signaling protein, transferase-transferase regulator complex glycosylation; HET: NAG; 3.03A {Homo sapiens} | Back alignment and structure |
|---|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
| >3u7u_G Neuregulin 1; signaling protein, transferase-transferase regulator complex glycosylation; HET: NAG; 3.03A {Homo sapiens} | Back alignment and structure |
|---|
| >1klo_A Laminin; glycoprotein; 2.10A {Mus musculus} SCOP: g.3.11.2 g.3.11.2 g.3.11.2 PDB: 1npe_B 1tle_A | Back alignment and structure |
|---|
| >2p28_B Integrin beta-2; hybrid domain, PSI domain, I-EGF DOM cell adhesion; HET: NAG; 2.20A {Homo sapiens} PDB: 1l3y_A | Back alignment and structure |
|---|
| >2p28_B Integrin beta-2; hybrid domain, PSI domain, I-EGF DOM cell adhesion; HET: NAG; 2.20A {Homo sapiens} PDB: 1l3y_A | Back alignment and structure |
|---|
| >2k2s_B Micronemal protein 6; microneme protein complex, cell adhesion, cytoplasmic vesicl lectin, virulence, EGF-like domain, membrane; NMR {Toxoplasma gondii} PDB: 2k2t_A | Back alignment and structure |
|---|
| >1a3p_A Epidermal growth factor; disulfide connectivities, EGF-like domain, repeat; HET: ABA; NMR {Mus musculus} SCOP: g.3.11.1 | Back alignment and structure |
|---|
| >2k2s_B Micronemal protein 6; microneme protein complex, cell adhesion, cytoplasmic vesicl lectin, virulence, EGF-like domain, membrane; NMR {Toxoplasma gondii} PDB: 2k2t_A | Back alignment and structure |
|---|
| >1hae_A Heregulin-alpha; growth factor; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1haf_A 1hre_A 1hrf_A | Back alignment and structure |
|---|
| >1a3p_A Epidermal growth factor; disulfide connectivities, EGF-like domain, repeat; HET: ABA; NMR {Mus musculus} SCOP: g.3.11.1 | Back alignment and structure |
|---|
| >2wg3_C Hedgehog-interacting protein; lipoprotein, development, membrane, secreted, protease, PALM hydrolase, developmental protein, autocatalytic cleavage; HET: NAG; 2.60A {Homo sapiens} PDB: 2wg4_B 2wfx_B 2wft_A 3ho3_A 3ho4_A 3ho5_A | Back alignment and structure |
|---|
| >1egf_A Epidermal growth factor; NMR {Mus musculus} SCOP: g.3.11.1 PDB: 1epg_A 1eph_A 1epi_A 1epj_A 3egf_A 1gk5_A | Back alignment and structure |
|---|
| >1egf_A Epidermal growth factor; NMR {Mus musculus} SCOP: g.3.11.1 PDB: 1epg_A 1eph_A 1epi_A 1epj_A 3egf_A 1gk5_A | Back alignment and structure |
|---|
| >2wg3_C Hedgehog-interacting protein; lipoprotein, development, membrane, secreted, protease, PALM hydrolase, developmental protein, autocatalytic cleavage; HET: NAG; 2.60A {Homo sapiens} PDB: 2wg4_B 2wfx_B 2wft_A 3ho3_A 3ho4_A 3ho5_A | Back alignment and structure |
|---|
| >1hae_A Heregulin-alpha; growth factor; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1haf_A 1hre_A 1hrf_A | Back alignment and structure |
|---|
| >3ca7_A Protein spitz; argos, EGF, developmental protein, differentiation, EGF-like domain, endoplasmic reticulum, glycoprotein, golgi apparatus; 1.50A {Drosophila melanogaster} PDB: 3c9a_C 3ltg_D | Back alignment and structure |
|---|
| >3zyj_B Netrin-G1; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
| >1kli_L Factor VIIA; extrinsic coagulation pathway, serine protease activation, R drug design, substrate-assisted catalysis, hydrolase; 1.69A {Homo sapiens} SCOP: g.3.11.1 PDB: 1klj_L 1jbu_L 1ygc_L* | Back alignment and structure |
|---|
| >2jkh_L Factor X light chain; plasma, calcium, zymogen, secreted, protease, hydrolase, polymorphism, glycoprotein, gamma-carboxyglutamic acid; HET: BI7; 1.25A {Homo sapiens} PDB: 2bok_L* 2vvc_K* 2vvu_L* 2vvv_L* 2vwl_L* 2vwm_K* 2vwn_L* 2vwo_L* 2xbv_L* 2xbw_L* 2xbx_L* 2xby_L* 2xc0_L* 2xc4_L* 2xc5_L* 2gd4_L* 3kl6_B* 2y5f_L* 2y5g_L* 2y5h_L* ... | Back alignment and structure |
|---|
| >1k36_A Epiregulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1k37_A | Back alignment and structure |
|---|
| >3zyj_B Netrin-G1; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
| >3ca7_A Protein spitz; argos, EGF, developmental protein, differentiation, EGF-like domain, endoplasmic reticulum, glycoprotein, golgi apparatus; 1.50A {Drosophila melanogaster} PDB: 3c9a_C 3ltg_D | Back alignment and structure |
|---|
| >1k36_A Epiregulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1k37_A | Back alignment and structure |
|---|
| >1apq_A Complement protease C1R; EGF, calcium binding, serine protease; NMR {Homo sapiens} SCOP: g.3.11.1 | Back alignment and structure |
|---|
| >1gl4_A Nidogen-1, entactin; immunoglobulin-like domain, extracellular matrix; HET: EPE; 2.0A {Mus musculus} SCOP: d.22.1.2 g.3.11.5 PDB: 1h4u_A | Back alignment and structure |
|---|
| >2kl7_A Fibulin-4; secreted, calcium, disease mutation, disulfide bond, EGF- like domain, glycoprotein, polymorphism, structural genomics, PSI-2; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A | Back alignment and structure |
|---|
| >1kig_L Factor XA; glycoprotein, serine protease, plasma, blood coagulation, complex (protease/inhibitor); 3.00A {Bos taurus} SCOP: g.3.11.1 | Back alignment and structure |
|---|
| >1ob1_C Major merozoite surface protein; immune system, immunoglobulin/complex, immunoglobulin, antib fragment, MSP1-19, EGF-like domain; 2.90A {Plasmodium falciparum} SCOP: g.3.11.4 g.3.11.4 PDB: 1cej_A 2flg_A | Back alignment and structure |
|---|
| >1nql_B Epidermal growth factor; cell surface receptor, tyrosine kinase, glycoprotein, endoso growth factor, auto-inhibition; HET: NAG BMA; 2.80A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ivo_C* 2kv4_A 1jl9_A 1p9j_A 3njp_C* | Back alignment and structure |
|---|
| >1nql_B Epidermal growth factor; cell surface receptor, tyrosine kinase, glycoprotein, endoso growth factor, auto-inhibition; HET: NAG BMA; 2.80A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ivo_C* 2kv4_A 1jl9_A 1p9j_A 3njp_C* | Back alignment and structure |
|---|
| >1gl4_A Nidogen-1, entactin; immunoglobulin-like domain, extracellular matrix; HET: EPE; 2.0A {Mus musculus} SCOP: d.22.1.2 g.3.11.5 PDB: 1h4u_A | Back alignment and structure |
|---|
| >1n1i_A Merozoite surface protein-1; MSP1, malaria, surface antigen, glycoprotein, EGF domain, cell adhesion; HET: HIS; 2.40A {Plasmodium knowlesi strain H} SCOP: g.3.11.4 g.3.11.4 | Back alignment and structure |
|---|
| >2jkh_L Factor X light chain; plasma, calcium, zymogen, secreted, protease, hydrolase, polymorphism, glycoprotein, gamma-carboxyglutamic acid; HET: BI7; 1.25A {Homo sapiens} PDB: 2bok_L* 2vvc_K* 2vvu_L* 2vvv_L* 2vwl_L* 2vwm_K* 2vwn_L* 2vwo_L* 2xbv_L* 2xbw_L* 2xbx_L* 2xby_L* 2xc0_L* 2xc4_L* 2xc5_L* 2gd4_L* 3kl6_B* 2y5f_L* 2y5g_L* 2y5h_L* ... | Back alignment and structure |
|---|
| >1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A | Back alignment and structure |
|---|
| >2kl7_A Fibulin-4; secreted, calcium, disease mutation, disulfide bond, EGF- like domain, glycoprotein, polymorphism, structural genomics, PSI-2; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >1ob1_C Major merozoite surface protein; immune system, immunoglobulin/complex, immunoglobulin, antib fragment, MSP1-19, EGF-like domain; 2.90A {Plasmodium falciparum} SCOP: g.3.11.4 g.3.11.4 PDB: 1cej_A 2flg_A | Back alignment and structure |
|---|
| >1kig_L Factor XA; glycoprotein, serine protease, plasma, blood coagulation, complex (protease/inhibitor); 3.00A {Bos taurus} SCOP: g.3.11.1 | Back alignment and structure |
|---|
| >1n1i_A Merozoite surface protein-1; MSP1, malaria, surface antigen, glycoprotein, EGF domain, cell adhesion; HET: HIS; 2.40A {Plasmodium knowlesi strain H} SCOP: g.3.11.4 g.3.11.4 | Back alignment and structure |
|---|
| >1kli_L Factor VIIA; extrinsic coagulation pathway, serine protease activation, R drug design, substrate-assisted catalysis, hydrolase; 1.69A {Homo sapiens} SCOP: g.3.11.1 PDB: 1klj_L 1jbu_L 1ygc_L* | Back alignment and structure |
|---|
| >1apq_A Complement protease C1R; EGF, calcium binding, serine protease; NMR {Homo sapiens} SCOP: g.3.11.1 | Back alignment and structure |
|---|
| >2bz6_L Blood coagulation factor VIIA; serine protease, enzyme complex, hydrolase; HET: 346; 1.6A {Homo sapiens} SCOP: g.3.11.1 PDB: 1w8b_L* 1w7x_L* 1cvw_L* | Back alignment and structure |
|---|
| >2fd6_A Urokinase-type plasminogen activator; UPAR, ATF, ATN-615 antibody, FAB, ternary complex, immune SY hydrolase; HET: PGE NAG FUC NDG PG4; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 3bt2_A* 3bt1_A* 3u73_A* 1urk_A* 3laq_A* 1kdu_A | Back alignment and structure |
|---|
| >2fd6_A Urokinase-type plasminogen activator; UPAR, ATF, ATN-615 antibody, FAB, ternary complex, immune SY hydrolase; HET: PGE NAG FUC NDG PG4; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 3bt2_A* 3bt1_A* 3u73_A* 1urk_A* 3laq_A* 1kdu_A | Back alignment and structure |
|---|
| >3ltf_D Protein spitz; receptor-ligand complex ectodomain cysteine rich domain EGF ATP-binding, kinase, nucleotide-binding, receptor; HET: NAG MAN; 3.20A {Drosophila melanogaster} | Back alignment and structure |
|---|
| >2wph_E Coagulation factor IXA light chain; serine protease, zymogen, hydrolase, glycoprotein, hydroxylation, phosphoprotein, sulfation, hemostasis; HET: DPN 1PE; 1.50A {Homo sapiens} PDB: 2wpi_E* 2wpj_E* 2wpk_E* 2wpl_E* 2wpm_E 3kcg_L* 3lc3_B* 1rfn_B* 3lc5_B* | Back alignment and structure |
|---|
| >3ltf_D Protein spitz; receptor-ligand complex ectodomain cysteine rich domain EGF ATP-binding, kinase, nucleotide-binding, receptor; HET: NAG MAN; 3.20A {Drosophila melanogaster} | Back alignment and structure |
|---|
| >2bz6_L Blood coagulation factor VIIA; serine protease, enzyme complex, hydrolase; HET: 346; 1.6A {Homo sapiens} SCOP: g.3.11.1 PDB: 1w8b_L* 1w7x_L* 1cvw_L* | Back alignment and structure |
|---|
| >1q4g_A Prostaglandin G/H synthase 1; cyclooxygenase, non-steroidal anti-inflammatory drug, peroxi prostaglandin synthase, EGF-like domain; HET: BOG NAG NDG BMA MAN BFL HEM; 2.00A {Ovis aries} SCOP: a.93.1.2 g.3.11.1 PDB: 1diy_A* 2ayl_A* 3kk6_A* 3n8v_A* 3n8w_A* 3n8x_A* 3n8y_A* 3n8z_A* 2oyu_P* 2oye_P* 1eqg_A* 1cqe_A* 1eqh_A* 1igz_A* 1igx_A* 1fe2_A* 1pge_A* 1pgf_A* 1pgg_A* 3n8w_B* ... | Back alignment and structure |
|---|
| >1q4g_A Prostaglandin G/H synthase 1; cyclooxygenase, non-steroidal anti-inflammatory drug, peroxi prostaglandin synthase, EGF-like domain; HET: BOG NAG NDG BMA MAN BFL HEM; 2.00A {Ovis aries} SCOP: a.93.1.2 g.3.11.1 PDB: 1diy_A* 2ayl_A* 3kk6_A* 3n8v_A* 3n8w_A* 3n8x_A* 3n8y_A* 3n8z_A* 2oyu_P* 2oye_P* 1eqg_A* 1cqe_A* 1eqh_A* 1igz_A* 1igx_A* 1fe2_A* 1pge_A* 1pgf_A* 1pgg_A* 3n8w_B* ... | Back alignment and structure |
|---|
| >3nt1_A Prostaglandin-endoperoxide synthase 2; prostaglandin H2 synthase, cyclooxygenase-2, naproxen, oxido; HET: NAG BOG NPS HEM; 1.73A {Mus musculus} PDB: 3ln1_A* 3mqe_A* 3ln0_A* 3ntb_A* 3q7d_A* 4fm5_A* 1pxx_A* 3pgh_A* 1cx2_A* 4cox_A* 5cox_A* 6cox_A* 3qh0_A* 3qmo_A* 4e1g_A* 3olu_A* 3olt_A* 3hs5_A* 3hs6_A* 3hs7_A* ... | Back alignment and structure |
|---|
| >3nt1_A Prostaglandin-endoperoxide synthase 2; prostaglandin H2 synthase, cyclooxygenase-2, naproxen, oxido; HET: NAG BOG NPS HEM; 1.73A {Mus musculus} PDB: 3ln1_A* 3mqe_A* 3ln0_A* 3ntb_A* 3q7d_A* 4fm5_A* 1pxx_A* 3pgh_A* 1cx2_A* 4cox_A* 5cox_A* 6cox_A* 3qh0_A* 3qmo_A* 4e1g_A* 3olu_A* 3olt_A* 3hs5_A* 3hs6_A* 3hs7_A* ... | Back alignment and structure |
|---|
| >1szb_A Mannose binding lectin-associated serine protease-2 related protein, MAP19 (19KDA)...; calcium, complement, innate immunity, CUB, EGF; 2.50A {Homo sapiens} SCOP: b.23.1.1 g.3.11.1 | Back alignment and structure |
|---|
| >2i9a_A Urokinase-type plasminogen activator; growth factor-like domain, kringle domain, hydrolase; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 2i9b_A* | Back alignment and structure |
|---|
| >1szb_A Mannose binding lectin-associated serine protease-2 related protein, MAP19 (19KDA)...; calcium, complement, innate immunity, CUB, EGF; 2.50A {Homo sapiens} SCOP: b.23.1.1 g.3.11.1 | Back alignment and structure |
|---|
| >2wph_E Coagulation factor IXA light chain; serine protease, zymogen, hydrolase, glycoprotein, hydroxylation, phosphoprotein, sulfation, hemostasis; HET: DPN 1PE; 1.50A {Homo sapiens} PDB: 2wpi_E* 2wpj_E* 2wpk_E* 2wpl_E* 2wpm_E 3kcg_L* 3lc3_B* 1rfn_B* 3lc5_B* | Back alignment and structure |
|---|
| >3e50_C Protransforming growth factor alpha; IDE, TGF-alpha, cytoplasm, hydrolase, metal-binding, metalloprotease, polymorphism, protease, zinc; 2.30A {Homo sapiens} SCOP: g.3.11.1 PDB: 1yuf_A 1yug_A 2tgf_A 1mox_C 3tgf_A 4tgf_A | Back alignment and structure |
|---|
| >1nzi_A Complement C1S component; calcium, innate immunity, modular structure, CUB, EGF, hydrolase; 1.50A {Homo sapiens} SCOP: b.23.1.1 g.3.11.1 | Back alignment and structure |
|---|
| >3f1s_B Vitamin K-dependent protein Z; PZ, ZPI, complex, serpin, protease inhibitor, protease, GLYC secreted, serine protease inhibitor, blood coagulation; HET: FLC NAG; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
| >3e50_C Protransforming growth factor alpha; IDE, TGF-alpha, cytoplasm, hydrolase, metal-binding, metalloprotease, polymorphism, protease, zinc; 2.30A {Homo sapiens} SCOP: g.3.11.1 PDB: 1yuf_A 1yug_A 2tgf_A 1mox_C 3tgf_A 4tgf_A | Back alignment and structure |
|---|
| >1g1t_A E-selectin; EGF, adhesion molecule, SLEX, immune system, membrane protein; HET: SIA GAL MAG FUC; 1.50A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1esl_A | Back alignment and structure |
|---|
| >2i9a_A Urokinase-type plasminogen activator; growth factor-like domain, kringle domain, hydrolase; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 2i9b_A* | Back alignment and structure |
|---|
| >2rnl_A Amphiregulin; AR, colorectum cell-derived growth factor, EGF-like domain, CRDGF, cytokine, glycoprotein, membrane, polymorphism, transmembrane; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >1iox_A Betacellulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1ip0_A | Back alignment and structure |
|---|
| >2rnl_A Amphiregulin; AR, colorectum cell-derived growth factor, EGF-like domain, CRDGF, cytokine, glycoprotein, membrane, polymorphism, transmembrane; NMR {Homo sapiens} | Back alignment and structure |
|---|
| >1iox_A Betacellulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1ip0_A | Back alignment and structure |
|---|
| >1xdt_R Hbegf, heparin-binding epidermal growth factor; complex (toxin-growth factor), diphtheria toxin, receptor, H binding epidermal growth factor; 2.65A {Homo sapiens} SCOP: g.3.11.1 | Back alignment and structure |
|---|
| >3v64_C Agrin; beta propeller, laminin-G, signaling, protein binding; HET: NAG; 2.85A {Rattus norvegicus} | Back alignment and structure |
|---|
| >4aqt_A Laminin subunit gamma-1; cell adhesion; HET: NAG BMA; 3.20A {Mus musculus} | Back alignment and structure |
|---|
| >1g1t_A E-selectin; EGF, adhesion molecule, SLEX, immune system, membrane protein; HET: SIA GAL MAG FUC; 1.50A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1esl_A | Back alignment and structure |
|---|
| >2ygo_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: MLY PCF NAG; 1.85A {Homo sapiens} PDB: 2ygp_A* | Back alignment and structure |
|---|
| >1xdt_R Hbegf, heparin-binding epidermal growth factor; complex (toxin-growth factor), diphtheria toxin, receptor, H binding epidermal growth factor; 2.65A {Homo sapiens} SCOP: g.3.11.1 | Back alignment and structure |
|---|
| >3asi_A Neurexin-1-alpha; beta-sandwich, cell adhesion, synapse maturation, neuroligin glycosylation, membrane; HET: NAG; 2.30A {Bos taurus} | Back alignment and structure |
|---|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1290 | ||||
| d1ux6a1 | 216 | b.29.1.16 (A:937-1152) Thrombospondin C-terminal d | 3e-71 | |
| d1ux6a1 | 216 | b.29.1.16 (A:937-1152) Thrombospondin C-terminal d | 3e-23 | |
| d1ux6a2 | 124 | g.75.1.1 (A:813-936) Thrombospondin-1 {Human (Homo | 5e-22 | |
| d1ux6a2 | 124 | g.75.1.1 (A:813-936) Thrombospondin-1 {Human (Homo | 5e-17 | |
| d1ux6a2 | 124 | g.75.1.1 (A:813-936) Thrombospondin-1 {Human (Homo | 1e-14 | |
| d1ux6a2 | 124 | g.75.1.1 (A:813-936) Thrombospondin-1 {Human (Homo | 5e-14 | |
| d1ux6a2 | 124 | g.75.1.1 (A:813-936) Thrombospondin-1 {Human (Homo | 1e-08 | |
| d1ux6a2 | 124 | g.75.1.1 (A:813-936) Thrombospondin-1 {Human (Homo | 3e-08 | |
| d1ux6a2 | 124 | g.75.1.1 (A:813-936) Thrombospondin-1 {Human (Homo | 0.001 | |
| d1ux6a2 | 124 | g.75.1.1 (A:813-936) Thrombospondin-1 {Human (Homo | 0.004 | |
| d1emoa1 | 43 | g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sa | 3e-04 | |
| d1apqa_ | 53 | g.3.11.1 (A:) Complement protease C1R {Human (Homo | 6e-04 | |
| d1uzka2 | 43 | g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sa | 7e-04 | |
| d1lmja2 | 42 | g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapien | 0.001 | |
| d1nt0a3 | 45 | g.3.11.1 (A:120-164) Mannose-binding protein assoc | 0.003 |
| >d1ux6a1 b.29.1.16 (A:937-1152) Thrombospondin C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 216 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Thrombospondin C-terminal domain domain: Thrombospondin C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (600), Expect = 3e-71
Identities = 83/139 (59%), Positives = 106/139 (76%)
Query: 998 TDFRRYTTVILDPQGTSQIDPHWVIYNHGAEILQTMNSDPGLAIGQDKFSGVDFEGTFFV 1057
TDFRR+ + LDP+GTSQ DP+WV+ + G E++QT+NSDPGLA+G D+F+ VDF GTFF+
Sbjct: 1 TDFRRFQMIPLDPKGTSQNDPNWVVRHQGKELVQTVNSDPGLAVGYDEFNAVDFSGTFFI 60
Query: 1058 DTDIDDDYAGFVFSYQSSQKFYVMMWKKNSQVYWQTTPFRAVAEPGIQLKVVDSATGPGT 1117
+T+ DDDYAGFVF YQSS +FYV+MWK+ +Q YW T P RA G+ +KVV S TGPG
Sbjct: 61 NTERDDDYAGFVFGYQSSSRFYVVMWKQVTQSYWDTNPTRAQGYSGLSVKVVKSTTGPGE 120
Query: 1118 MLRNSLWHTGDTENQCDLA 1136
LRN+LWHTG+T Q
Sbjct: 121 HLRNALWHTGNTPGQVRTL 139
|
| >d1ux6a1 b.29.1.16 (A:937-1152) Thrombospondin C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 216 | Back information, alignment and structure |
|---|
| >d1ux6a2 g.75.1.1 (A:813-936) Thrombospondin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 124 | Back information, alignment and structure |
|---|
| >d1ux6a2 g.75.1.1 (A:813-936) Thrombospondin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 124 | Back information, alignment and structure |
|---|
| >d1ux6a2 g.75.1.1 (A:813-936) Thrombospondin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 124 | Back information, alignment and structure |
|---|
| >d1ux6a2 g.75.1.1 (A:813-936) Thrombospondin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 124 | Back information, alignment and structure |
|---|
| >d1ux6a2 g.75.1.1 (A:813-936) Thrombospondin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 124 | Back information, alignment and structure |
|---|
| >d1ux6a2 g.75.1.1 (A:813-936) Thrombospondin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 124 | Back information, alignment and structure |
|---|
| >d1ux6a2 g.75.1.1 (A:813-936) Thrombospondin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 124 | Back information, alignment and structure |
|---|
| >d1ux6a2 g.75.1.1 (A:813-936) Thrombospondin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 124 | Back information, alignment and structure |
|---|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 43 | Back information, alignment and structure |
|---|
| >d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} Length = 53 | Back information, alignment and structure |
|---|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 43 | Back information, alignment and structure |
|---|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 42 | Back information, alignment and structure |
|---|
| >d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 45 | Back information, alignment and structure |
|---|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1290 | |||
| d1ux6a1 | 216 | Thrombospondin C-terminal domain {Human (Homo sapi | 100.0 | |
| d1ux6a1 | 216 | Thrombospondin C-terminal domain {Human (Homo sapi | 100.0 | |
| d1ux6a2 | 124 | Thrombospondin-1 {Human (Homo sapiens) [TaxId: 960 | 99.9 | |
| d1ux6a2 | 124 | Thrombospondin-1 {Human (Homo sapiens) [TaxId: 960 | 99.87 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 98.14 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 98.1 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 98.09 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 98.08 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 98.07 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 98.05 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 98.04 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 98.02 | |
| d2c4fl1 | 37 | Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | 98.01 | |
| d2c4fl1 | 37 | Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | 98.01 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 97.96 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 97.96 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 97.89 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 97.85 | |
| d1tpga1 | 41 | Plasminogen activator (tissue-type), t-PA {Human ( | 97.83 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 97.71 | |
| d1uzka2 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 97.69 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 97.67 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 97.64 | |
| d1g1sa2 | 40 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 97.63 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 97.62 | |
| d1g1ta2 | 39 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 97.61 | |
| d1apqa_ | 53 | Complement protease C1R {Human (Homo sapiens) [Tax | 97.59 | |
| d1g1ta2 | 39 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 97.54 | |
| d1g1sa2 | 40 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 97.52 | |
| d1tpga1 | 41 | Plasminogen activator (tissue-type), t-PA {Human ( | 97.5 | |
| d1autl1 | 48 | Activated protein c (autoprothrombin IIa) {Human ( | 97.29 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 97.29 | |
| d1q4ga2 | 42 | Prostaglandin H2 synthase-1, EGF-like module {Shee | 97.27 | |
| d1q4ga2 | 42 | Prostaglandin H2 synthase-1, EGF-like module {Shee | 97.26 | |
| d1szba2 | 45 | Mannose-binding protein associated serine protease | 97.23 | |
| d1autl1 | 48 | Activated protein c (autoprothrombin IIa) {Human ( | 97.2 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 97.19 | |
| d1nt0a3 | 45 | Mannose-binding protein associated serine protease | 97.18 | |
| d1cvua2 | 41 | Prostaglandin H2 synthase-1, EGF-like module {Mous | 97.18 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 97.17 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 97.14 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 97.13 | |
| d1cvua2 | 41 | Prostaglandin H2 synthase-1, EGF-like module {Mous | 97.11 | |
| d1nzia2 | 42 | Complement C1S component {Human (Homo sapiens) [Ta | 96.98 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 96.81 | |
| d1haea_ | 63 | Heregulin-alpha, EGF-like domain {Human (Homo sapi | 96.81 | |
| d1haea_ | 63 | Heregulin-alpha, EGF-like domain {Human (Homo sapi | 96.8 | |
| d1dx5i3 | 40 | Thrombomodulin, different EGF-like domains {Human | 96.79 | |
| d1uzka2 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 96.75 | |
| d3bpse1 | 40 | Low density lipoprotein (LDL) receptor, different | 96.73 | |
| d1apqa_ | 53 | Complement protease C1R {Human (Homo sapiens) [Tax | 96.66 | |
| d3egfa_ | 53 | Epidermal growth factor, EGF {Mouse (Mus musculus) | 96.64 | |
| d1dx5i3 | 40 | Thrombomodulin, different EGF-like domains {Human | 96.62 | |
| d3egfa_ | 53 | Epidermal growth factor, EGF {Mouse (Mus musculus) | 96.42 | |
| d1nt0a3 | 45 | Mannose-binding protein associated serine protease | 96.33 | |
| d1szba2 | 45 | Mannose-binding protein associated serine protease | 96.31 | |
| d1nqlb_ | 48 | Epidermal growth factor, EGF {Human (Homo sapiens) | 95.94 | |
| d1nqlb_ | 48 | Epidermal growth factor, EGF {Human (Homo sapiens) | 95.74 | |
| d1kigl_ | 51 | Factor X, N-terminal module {Cow (Bos taurus) [Tax | 95.61 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 95.55 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 95.38 | |
| d1autl2 | 50 | Activated protein c (autoprothrombin IIa) {Human ( | 95.29 | |
| d1nzia2 | 42 | Complement C1S component {Human (Homo sapiens) [Ta | 95.18 | |
| d2p3ua1 | 51 | Factor X, N-terminal module {Human (Homo sapiens) | 94.87 | |
| d3bpse1 | 40 | Low density lipoprotein (LDL) receptor, different | 94.84 | |
| d1ijqa2 | 50 | Low density lipoprotein (LDL) receptor, different | 94.28 | |
| d1ioxa_ | 50 | Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606] | 93.36 | |
| d1moxc_ | 49 | Transforming growth factor alpha {Human (Homo sapi | 92.87 | |
| d1k36a_ | 46 | Epiregulin, EGF-domain {Human (Homo sapiens) [TaxI | 92.07 | |
| d1rfnb_ | 57 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 91.77 | |
| d1ioxa_ | 50 | Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606] | 91.68 | |
| d1kigl_ | 51 | Factor X, N-terminal module {Cow (Bos taurus) [Tax | 90.79 | |
| d1k36a_ | 46 | Epiregulin, EGF-domain {Human (Homo sapiens) [TaxI | 90.44 | |
| d2i9aa1 | 40 | Plasminogen activator (urokinase-type) {Human (Hom | 89.54 | |
| d1moxc_ | 49 | Transforming growth factor alpha {Human (Homo sapi | 89.16 | |
| d2bz6l1 | 53 | Coagulation factor VIIa {Human (Homo sapiens) [Tax | 89.13 | |
| d1autl2 | 50 | Activated protein c (autoprothrombin IIa) {Human ( | 88.98 | |
| d1uzka3 | 76 | Fibrillin {Human (Homo sapiens) [TaxId: 9606]} | 87.79 | |
| d2i9aa1 | 40 | Plasminogen activator (urokinase-type) {Human (Hom | 87.12 | |
| d1gl4a1 | 233 | Domain G2 of nidogen-1 {Mouse (Mus musculus) [TaxI | 86.85 | |
| d1apja_ | 74 | Fibrillin {Human (Homo sapiens) [TaxId: 9606]} | 86.79 | |
| d2p3ua1 | 51 | Factor X, N-terminal module {Human (Homo sapiens) | 85.04 | |
| d1xdtr_ | 41 | Heparin-binding epidermal growth factor, HBEGF {Hu | 81.01 |
| >d1ux6a1 b.29.1.16 (A:937-1152) Thrombospondin C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Thrombospondin C-terminal domain domain: Thrombospondin C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=405.76 Aligned_cols=155 Identities=57% Similarity=1.024 Sum_probs=147.2
Q ss_pred cccccceeeecCCCCCcCCCCceeeccCCceEEEeecCCCCcccccccccceeeecceeecccCCCCccceEeeeccCCc
Q psy620 998 TDFRRYTTVILDPQGTSQIDPHWVIYNHGAEILQTMNSDPGLAIGQDKFSGVDFEGTFFVDTDIDDDYAGFVFSYQSSQK 1077 (1290)
Q Consensus 998 ~d~~~~~~~~~d~~g~~~~d~~~~v~~~g~~~~q~~~~dp~~~~g~~~~~~~d~~g~~~~~~~~d~~~~gfvf~yq~~~~ 1077 (1290)
|||+.|++|.|||.|++|.+|+|+|+|+|+||+|++||||+|+||+++|.+|||+|||+||++.|||||||||+||||++
T Consensus 1 tdf~~~~~v~ldp~g~~q~~P~W~v~n~G~eI~Qt~NsdP~l~ig~~~~~~Vdf~GTf~Vnt~~DDD~iGFVFgYQss~~ 80 (216)
T d1ux6a1 1 TDFRRFQMIPLDPKGTSQNDPNWVVRHQGKELVQTVNSDPGLAVGYDEFNAVDFSGTFFINTERDDDYAGFVFGYQSSSR 80 (216)
T ss_dssp CCTTCCEEEESCSSCCSSCCCCEEC-----CEEECSSCSCEEEEEEEEESSEEEEEEEEECCSSCCCEEEEEEEEEETTE
T ss_pred CCcccceEEEcCCCCCCCCCCCeEEecCCcEEEEeccCCCeEEEccceeccEEEEEEEEECCCCCCCEEEEEEEEecCCe
Confidence 68999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeccccceeeeeccccccccCCccEEEEecCCCCCCcccccccccCCCcccccccCCCcCCCcccccCCCCcc
Q psy620 1078 FYVMMWKKNSQVYWQTTPFRAVAEPGIQLKVVDSATGPGTMLRNSLWHTGDTENQCDLAEPCDPRVQCTNLFPGYR 1153 (1290)
Q Consensus 1078 f~~~~~~~~~~~~w~~~~f~~~~~~g~~~~~~~~~~~~~~~~~~~~w~~~~~~~q~~~~w~~~~~~~~~~~~~~~~ 1153 (1290)
||||||||..|+||+.+||||.|++|||+|+|+|+||||++|||+|||+++|.+||++||| ||++++|+....|+
T Consensus 81 FYvv~WKq~~q~yw~~~p~~a~g~~GiqlK~V~s~TGpg~~l~nalWhtg~t~~qv~llw~-dp~~~GW~~~taYr 155 (216)
T d1ux6a1 81 FYVVMWKQVTQSYWDTNPTRAQGYSGLSVKVVKSTTGPGEHLRNALWHTGNTPGQVRTLWH-DPRHIGWKDFTAYR 155 (216)
T ss_dssp EEEEEEESSCEECSCCSSSCCEECSEEEEEEEECSSCTTHHHHHHHHSSSCBTTTEEEEEE-CTTCCCCCTTCEEE
T ss_pred EEEEEeeecceeeeccCCccccCcCceEEEeecCCcCcchhhhhhhcccCCcchhhheecc-CccccCCccCceEE
Confidence 9999999999999999999999999999999999999999999999999999999999999 99999888887776
|
| >d1ux6a1 b.29.1.16 (A:937-1152) Thrombospondin C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1ux6a2 g.75.1.1 (A:813-936) Thrombospondin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1ux6a2 g.75.1.1 (A:813-936) Thrombospondin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]} | Back information, alignment and structure |
|---|
| >d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]} | Back information, alignment and structure |
|---|
| >d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
| >d1cvua2 g.3.11.1 (A:33-73) Prostaglandin H2 synthase-1, EGF-like module {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1cvua2 g.3.11.1 (A:33-73) Prostaglandin H2 synthase-1, EGF-like module {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1nzia2 g.3.11.1 (A:118-159) Complement C1S component {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1haea_ g.3.11.1 (A:) Heregulin-alpha, EGF-like domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1haea_ g.3.11.1 (A:) Heregulin-alpha, EGF-like domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d3bpse1 g.3.11.1 (E:293-332) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
| >d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1kigl_ g.3.11.1 (L:) Factor X, N-terminal module {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1autl2 g.3.11.1 (L:97-146) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1nzia2 g.3.11.1 (A:118-159) Complement C1S component {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2p3ua1 g.3.11.1 (A:87-137) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d3bpse1 g.3.11.1 (E:293-332) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1ijqa2 g.3.11.1 (A:643-692) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1ioxa_ g.3.11.1 (A:) Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1moxc_ g.3.11.1 (C:) Transforming growth factor alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1k36a_ g.3.11.1 (A:) Epiregulin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1rfnb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1ioxa_ g.3.11.1 (A:) Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1kigl_ g.3.11.1 (L:) Factor X, N-terminal module {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
| >d1k36a_ g.3.11.1 (A:) Epiregulin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2i9aa1 g.3.11.1 (A:10-49) Plasminogen activator (urokinase-type) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1moxc_ g.3.11.1 (C:) Transforming growth factor alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2bz6l1 g.3.11.1 (L:90-142) Coagulation factor VIIa {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1autl2 g.3.11.1 (L:97-146) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1uzka3 g.23.1.1 (A:1529-1604) Fibrillin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2i9aa1 g.3.11.1 (A:10-49) Plasminogen activator (urokinase-type) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1gl4a1 d.22.1.2 (A:399-631) Domain G2 of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
| >d1apja_ g.23.1.1 (A:) Fibrillin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d2p3ua1 g.3.11.1 (A:87-137) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1xdtr_ g.3.11.1 (R:) Heparin-binding epidermal growth factor, HBEGF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|